Study (identified by PubMed ID)Disease/TraitP-valuePlatform [SNPs passing QC]RegionReported Gene(s)Reported SNPs
19169254PsoriasisPendingPerlegen [~2.5 million] (imputed)PendingPendingrs20541
19169254PsoriasisPendingPerlegen [~2.5 million] (imputed)PendingPendingrs12191877
19169254PsoriasisPendingPerlegen [~2.5 million] (imputed)PendingPendingrs17728338
19169254PsoriasisPendingPerlegen [~2.5 million] (imputed)PendingPendingrs610604
19169254PsoriasisPendingPerlegen [~2.5 million] (imputed)PendingPendingrs2201841
19169254PsoriasisPendingPerlegen [~2.5 million] (imputed)PendingPendingrs2066808
19169254PsoriasisPendingPerlegen [~2.5 million] (imputed)PendingPendingrs1076160
19169254PsoriasisPendingPerlegen [~2.5 million] (imputed)PendingPendingrs2082412
19169255Psoriasis3.00E-26Illumina [494,902]5q33.3IL12Brs3213094
19169255Psoriasis7.00E-30Illumina [494,902]1q21.3LCE3D, LCE3Ars4085613
19169255PsoriasisNSIllumina [494,902]6p21.33MHCrs1265181
19148276Plasma levels of polyunsaturated fatty acidsPendingIllumina [495,343]PendingPending
19132087Kawasaki disease0.000001Affymetrix [223,922]3q26.31NAALADL2rs17531088
19132087Kawasaki disease0.000002Affymetrix [223,922]16q22.3ZFHX3rs7199343
19124843Plasma Lp (a) levels4.00E-11Affymetrix [290,327]6q25.3LPArs6919346
19122664Ulcerative colitis7.00E-09Illumina [280,748]1p36.13RNF186rs3806308
19122664Ulcerative colitis0.000002Illumina [280,748]9q21.32Intergenicrs668853
19122664Ulcerative colitis5.00E-07Illumina [280,748]12q15IL26rs2870946
19122664Ulcerative colitis3.00E-12Illumina [280,748]12q15IFNG, IL26, IL22rs1558744
19122664Ulcerative colitis1.00E-16Illumina [280,748]6p21.32BTNL2, HLA-DRA, HLA-DRB5, HLA-DRB1, HLA-DQA1, HLA-DQB1rs2395185
19122664Ulcerative colitis1.00E-08Illumina [280,748]1p31.3IL23Rrs11209026
19122664Ulcerative colitis0.000009Illumina [280,748]7q31.1SLC26A3, DLD, LAMB1rs4730276
19122664Ulcerative colitis0.000007Illumina [280,748]7q31.1SLC26A3, DLD, LAMB1rs2158836
19122664Ulcerative colitis1.00E-08Illumina [280,748]1p31.3IL23Rrs10889677
19122664Ulcerative colitis0.000001Illumina [280,748]7q31.1SLC26A3, DLD, LAMB1rs4598195
19122664Ulcerative colitis5.00E-13Illumina [280,748]1p36.13OTUD3, PLA2G2Ers6426833
19122664Ulcerative colitis0.000005Illumina [280,748]7q31.1Intergenicrs4730273
19118814Alzheimer's disease0.000002Illumina [~2.5 million] (imputed)19q13.31ZNF224rs2061333
19118814Alzheimer's disease3.00E-07Illumina [~2.5 million] (imputed)12q13.11FAM113Brs11610206
19118814Alzheimer's disease0.000009Illumina [~2.5 million] (imputed)1q42.2DISC1rs12044355
19115949AIDS progression6.00E-08Illumina [291,119]6p21.33HLA-Crs10484554
19115949AIDS progression3.00E-19Illumina [291,119]6p21.33HCP5, MICB, MCCD1, BAT1, LTB, TNFrs2395029
19115949AIDS progression5.00E-07Illumina [291,119]6p21.33ZNRD1, RNF39rs8321
19114987Bipolar disorderPendingAffymetrix [51,757 CNVs]PendingPending
19114657Blood pressure2.00E-07Affymetrix [79,447]2q24.3STK39rs6749447
19110211Mean platelet volume7.00E-48Affymetrix [335,152]12q24.31WDR66rs7961894
19110211Mean platelet volume7.00E-28Affymetrix [335,152]17q11.2TAOK1rs2138852
19110211Mean platelet volume4.00E-27Affymetrix [335,152]3p14.3ARHGEF3rs12485738
19107115Major depressive disorder0.000006Illumina and Affymetrix [494,678] (imputed)12p13.32CCND2rs4238010
19084217Serum markers of iron status1.00E-09Affymetrix [100,846]3q22.1TFrs1830084
19084217Serum markers of iron status1.00E-10Illumina [315,887]6p22.1HFErs1800562
19084217Serum markers of iron status6.00E-08Illumina [315,887]6p22.1BTN1A1rs13194984
19084217Serum markers of iron status1.00E-08Illumina [315,887]6p22.1HIST1H2BJrs13194491
19084217Serum markers of iron status4.00E-15Illumina [315,887]6p22.1HFErs1800562
19084217Serum markers of iron status0.000002Illumina [315,887]11p14.3LUZP2rs10500991
19084217Serum markers of iron status0.000002Illumina [315,887]3q22.1TFrs1867504
19084217Serum markers of iron status0.000002Illumina [315,887]Xq24KLHL13rs2430212
19084217Serum markers of iron status0.000001Illumina [315,887]3q22.1TOPBP1rs2718812
19084217Serum markers of iron status3.00E-07Illumina [315,887]6p22.2LRRC16rs2274089
19084217Serum markers of iron status3.00E-15Illumina [315,887]3q22.1TFrs3811647
19084217Serum markers of iron status0.000008Illumina [315,887]18q22.2Intergenicrs2660917
19084217Serum markers of iron status0.000008Illumina [315,887]5q14.1ARSBrs2052550
19084217Serum markers of iron status0.000007Illumina [315,887]7p14.1Q4KMW4rs29880
19084217Serum markers of iron status0.000001Illumina [315,887]6q25.3WTAPrs4516970
19084217Serum markers of iron status0.000008Illumina [315,887]5p12GHRrs13188386
19084217Serum markers of iron status0.000004Illumina [315,887]6p22.1TRIM38rs12216125
19084217Serum markers of iron status0.000003Illumina [315,887]2p14Q6ZNG6rs1457451
19084217Serum markers of iron status8.00E-07Illumina [315,887]6p22.2LRRC16rs2274089
19084217Serum markers of iron status4.00E-11Illumina [315,887]6p22.1HFErs1800562
19084217Serum markers of iron status0.000005Illumina [315,887]3q22.1TFrs1799852
19084217Serum markers of iron status0.000005Illumina [315,887]6p22.2LRRC16Ars2274089
19084217Serum markers of iron status0.000009Illumina [315,887]6p22.2SCGNrs932316
19084217Serum markers of iron status5.00E-07Illumina [315,887]6p22.2SLC17A1rs17270561
19084217Serum markers of iron status0.000003Affymetrix [100,846]14q23.2Q6ZUR9rs973968
19084217Serum markers of iron status0.000006Illumina [315,887]22q12.3TMPRSS6rs4820268
19084217Serum markers of iron status0.000002Affymetrix [100,846]6q22.33RSPO3rs972275
19074352Triglycerides3.00E-29Affymetrix [381,934]11q23.3APOA1, APOC3, APOA4, APOA5, DSCAML1rs10892151
19079262Bone mineral density (hip)4.00E-10Illumina [305,051]6q25.1ESR1rs1038304
19079262Bone mineral density (hip)9.00E-07Illumina [305,051]17q21.31C17orf53rs227584
19079262Bone mineral density (hip)2.00E-08Illumina [305,051]17q21.31SOSTrs1513670
19079262Bone mineral density (hip)0.000001Illumina [305,051]Xq21.2NRrs2710057
19079262Bone mineral density (hip)7.00E-07Illumina [305,051]11p11.2LRP4rs1007738
19079262Bone mineral density (hip)0.000009Illumina [305,051]3p22.1NRrs10490823
19079262Bone mineral density (hip)0.000002Illumina [305,051]2q12.1NRrs6735786
19079262Bone mineral density (hip)1.00E-16Illumina [305,051]1p36.12Intergenicrs7524102
19079262Bone mineral density (spine)2.00E-17Illumina [305,051]13q14.11RANKLrs9594759
19079262Bone mineral density (spine)0.000006Illumina [305,051]21q11.2NRrs1006899
19079262Bone mineral density (spine)0.000004Illumina [305,051]2p16.2SPTBN1rs11898505
19079262Bone mineral density (spine)2.00E-10Illumina [305,051]6q25.1C6orf97, ESR1rs6929137
19079262Bone mineral density (spine)0.000004Illumina [305,051]2p22.2LOC344382rs4670779
19079262Bone mineral density (spine)2.00E-08Illumina [305,051]1p36.12Intergenicrs6696981
19079262Bone mineral density (spine)1.00E-07Illumina [305,051]12q13.13OSXrs10876432
19079260Body mass index6.00E-08Illumina [305,846]1q25.2SEC16B, RASAL2rs10913469
19079260Body mass index7.00E-12Illumina [305,846]19q13.11KCTD15, CHST8rs29941
19079260Body mass index1.00E-12Illumina [305,846]18q21.32MC4Rrs12970134
19079260Body mass index1.00E-47Illumina [305,846]16q12.2FTOrs8050136
19079260Body mass index9.00E-10Illumina [305,846]11p14.1BDNFrs925946
19079260Body mass index0.000008Illumina [305,846]11p14.1BDNFrs7481311
19079260Body mass index7.00E-11Illumina [305,846]3q27.2SFRS10, ETV5, DGKGrs7647305
19079260Body mass index4.00E-17Illumina [305,846]2p25.3TMEM18rs7561317
19079260Body mass index1.00E-11Illumina [305,846]1p31.1NEGR1rs2568958
19079260Body mass index0.000004Illumina [305,846]1p21.3NRrs10783050
19079260Body mass index5.00E-10Illumina [305,846]11p14.1BDNFrs6265
19079260Body mass index1.00E-07Illumina [305,846]12q13.13BCDIN3D, FAIM2rs7138803
19079260Body mass index4.00E-13Illumina [305,846]16q12.2FTOrs6499640
19079260Body mass index3.00E-10Illumina [305,846]16p11.2SH2B1, ATP2A1rs7498665
19079260Weight2.00E-18Illumina [305,846]2p25.3TMEM18rs7561317
19079260Weight2.00E-08Illumina [305,846]6p21.33AIF1, NCR3rs2844479
19079260Weight4.00E-09Illumina [305,846]3q27.2SFRS10, ETV5, DGKGrs7647305
19079260Weight4.00E-09Illumina [305,846]11p14.1BDNFrs925946
19079260Weight0.000003Illumina [305,846]11p14.1BDNFrs7481311
19079260Weight1.00E-08Illumina [305,846]1q25.2SEC16B, RASAL2rs10913469
19079260Weight2.00E-08Illumina [305,846]1p31.1NEGR1rs2568958
19079260Weight0.000002Illumina [305,846]5q23.2NRrs2115172
19079260Weight0.000001Illumina [305,846]1p21.3NRrs1973993
19079260Weight5.00E-09Illumina [305,846]19q13.11KCTD15, CHST8rs29941
19079260Weight5.00E-13Illumina [305,846]18q21.32MC4Rrs12970134
19079260Weight5.00E-36Illumina [305,846]16q12.2FTOrs8050136
19079260Weight6.00E-14Illumina [305,846]16q12.2FTOrs6499640
19079260Weight1.00E-09Illumina [305,846]16p11.2SH2B1, ATP2A1rs7498665
19079260Weight0.000001Illumina [305,846]13q12.2NRrs7336332
19079260Weight2.00E-07Illumina [305,846]12q13.13BCDIN3D, FAIM2rs7138803
19079260Weight2.00E-07Illumina [305,846]11p14.1BDNFrs6265
19079261Body mass index4.00E-51Illumina and Affymetrix [2,399,588] (imputed)16q12.2FTOrs9939609
19079261Body mass index3.00E-16Illumina and Affymetrix [2,399,588] (imputed)4p13GNPDA2rs10938397
19079261Body mass index5.00E-09Illumina and Affymetrix [2,399,588] (imputed)11p11.2MTCH2rs10838738
19079261Body mass index6.00E-08Illumina and Affymetrix [2,399,588] (imputed)1p31.1NEGR1rs2815752
19079261Body mass index0.000007Illumina and Affymetrix [2,399,588] (imputed)15q25.2RKHD3rs12324805
19079261Body mass index0.000006Illumina and Affymetrix [2,399,588] (imputed)20p12.3BMP2rs2145270
19079261Body mass index0.000001Illumina and Affymetrix [2,399,588] (imputed)11p15.4STK33rs10769908
19079261Body mass index2.00E-08Illumina and Affymetrix [2,399,588] (imputed)19q13.11KCTD15rs11084753
19079261Body mass index5.00E-11Illumina and Affymetrix [2,399,588] (imputed)16p11.2SH2B1rs7498665
19079261Body mass index5.00E-18Illumina and Affymetrix [2,399,588] (imputed)18q21.32MC4Rrs17782313
19079261Body mass index1.00E-18Illumina and Affymetrix [2,399,588] (imputed)2p25.3TMEM18rs6548238
19081515Creutzfeldt-Jakob disease2.00E-21Affymetrix [288,908]20p13PRNPrs1799990
19081515Creutzfeldt-Jakob disease6.00E-08Affymetrix [288,908]8q21.13STMN2rs1460163
19065144Major depressive disorderNSPerlegen [435,291]NRNR
19060911Cholesterol, total5.00E-10Illumina and Affymetrix [up to ~600,000]1p36.11TMEM57rs10903129
19060911Cholesterol, total9.00E-24Illumina and Affymetrix [up to ~600,000]19p13.2LDLRrs2228671
19060911Cholesterol, total3.00E-19Illumina and Affymetrix [up to ~600,000]19q13.32TOMM40, APOErs2075650
19060911Cholesterol, total2.00E-15Illumina and Affymetrix [up to ~600,000]19p13.11NCANrs2304130
19060911Cholesterol, total2.00E-11Illumina and Affymetrix [up to ~600,000]18q21.1LIPGrs4939883
19060911Cholesterol, total9.00E-23Illumina and Affymetrix [up to ~600,000]2p24.1APOBrs693
19060911Cholesterol, total2.00E-10Illumina and Affymetrix [up to ~600,000]11q12.2FADS2, FADS3rs174570
19060911Cholesterol, total4.00E-12Illumina and Affymetrix [up to ~600,000]1p31.3DOCK7rs10889353
19060911Cholesterol, total9.00E-22Illumina and Affymetrix [up to ~600,000]1p13.3CELSR2rs646776
19060911Cholesterol, total2.00E-11Illumina and Affymetrix [up to ~600,000]2p21ABCG5rs6756629
19060911Cholesterol, total4.00E-07Illumina and Affymetrix [up to ~600,000]15q22.1LIPCrs1532085
19060911Cholesterol, total7.00E-07Illumina and Affymetrix [up to ~600,000]11q23.3APOA1, APOA4, APOA5, APOC3rs12272004
19060911Cholesterol, total3.00E-09Illumina and Affymetrix [up to ~600,000]8q24.13TRIB1rs6987702
19060911Cholesterol, total9.00E-07Illumina and Affymetrix [up to ~600,000]7p15.3DNAH11rs12670798
19060911Cholesterol, total3.00E-19Illumina and Affymetrix [up to ~600,000]5q13.3HMGCRrs3846662
19060911HDL cholesterol6.00E-11Illumina and Affymetrix [up to ~600,000]11p11.2MADD, FOLH1rs7395662
19060911HDL cholesterol8.00E-16Illumina and Affymetrix [up to ~600,000]16q22.1CTCF, PRMT8rs2271293
19060911HDL cholesterol4.00E-08Illumina and Affymetrix [up to ~600,000]2p24.1APOBrs6754295
19060911HDL cholesterol9.00E-13Illumina and Affymetrix [up to ~600,000]9q31.1ABCA1rs3905000
19060911HDL cholesterol1.00E-35Illumina and Affymetrix [up to ~600,000]15q22.1LIPCrs1532085
19060911HDL cholesterol4.00E-07Illumina and Affymetrix [up to ~600,000]19q13.32TOMM40, APOErs157580
19060911HDL cholesterol2.00E-11Illumina and Affymetrix [up to ~600,000]18q21.1LIPGrs4939883
19060911HDL cholesterol0.000004Illumina and Affymetrix [up to ~600,000]11q12.2FADS2, FADS3rs174570
19060911HDL cholesterol6.00E-18Illumina and Affymetrix [up to ~600,000]8p21.3LPLrs2083637
19060911HDL cholesterol9.00E-94Illumina and Affymetrix [up to ~600,000]16q13CETPrs1532624
19060911LDL cholesterol4.00E-17Illumina and Affymetrix [up to 600,000]2p24.1APOBrs693
19060911LDL cholesterol5.00E-13Illumina and Affymetrix [up to 600,000]11q23.3APOA1, APOA4, APOA5, APOC3rs12272004
19060911LDL cholesterol2.00E-19Illumina and Affymetrix [up to 600,000]19q13.32TOMM40, APOErs157580
19060911LDL cholesterol0.000003Illumina and Affymetrix [up to 600,000]19p13.11NCANrs2304130
19060911LDL cholesterol4.00E-14Illumina and Affymetrix [up to 600,000]19p13.2LDLRrs2228671
19060911LDL cholesterol0.000003Illumina and Affymetrix [up to 600,000]8q24.13TRIB1rs6987702
19060911LDL cholesterol3.00E-10Illumina and Affymetrix [up to 600,000]2p21ABCG5rs6756629
19060911LDL cholesterol0.000008Illumina and Affymetrix [up to 600,000]1p31.3DOCK7rs10889353
19060911LDL cholesterol8.00E-23Illumina and Affymetrix [up to 600,000]1p13.3CELSR2rs646776
19060911LDL cholesterol2.00E-11Illumina and Affymetrix [up to 600,000]5q13.3HMGCRrs3846662
19060911LDL cholesterol4.00E-13Illumina and Affymetrix [up to 600,000]11q12.2FADS2, FADS3rs174570
19060911LDL cholesterol6.00E-09Illumina and Affymetrix [up to 600,000]7p15.3DNAH11rs12670798
19060911Triglycerides2.00E-12Illumina and Affymetrix [up to 600,000]1p31.3DOCK7rs1167998
19060911Triglycerides5.00E-13Illumina and Affymetrix [up to 600,000]11q23.3APOA1, APOA4, APOA5, APOC3rs12272004
19060911Triglycerides1.00E-12Illumina and Affymetrix [up to 600,000]7q11.23MLXIPLrs2240466
19060911Triglycerides0.000003Illumina and Affymetrix [up to 600,000]19p13.11NCANrs2304130
19060911Triglycerides3.00E-20Illumina and Affymetrix [up to 600,000]2p23.3GCKRrs780094
19060911Triglycerides2.00E-09Illumina and Affymetrix [up to 600,000]19q13.32TOMM40, APOErs439401
19060911Triglycerides2.00E-18Illumina and Affymetrix [up to 600,000]8p21.3LPLrs10096633
19060911Triglycerides3.00E-08Illumina and Affymetrix [up to 600,000]2p24.1APOBrs6754295
19060909Fasting plasma glucose2.00E-36Illumina [308,846]11q21MTNR1Brs1387153
19060906HDL cholesterol2.00E-12Affymetrix and Illumina [~2,600,000] (imputed)11q12.2FADS1, FADS2, FADS3rs174547
19060906HDL cholesterol8.00E-10Affymetrix and Illumina [~2,600,000] (imputed)20q13.2HNF4Ars1800961
19060906HDL cholesterol3.00E-10Affymetrix and Illumina [~2,600,000] (imputed)9p22.3TTC39Brs471364
19060906HDL cholesterol4.00E-09Affymetrix and Illumina [~2,600,000] (imputed)20q13.12PLTPrs7679
19060906HDL cholesterol9.00E-13Affymetrix and Illumina [~2,600,000] (imputed)16q22.1LCATrs2271293
19060906HDL cholesterol2.00E-34Affymetrix and Illumina [~2,600,000] (imputed)8p21.3LPLrs12678919
19060906HDL cholesterol7.00E-15Affymetrix and Illumina [~2,600,000] (imputed)18q21.1LIPGrs4939883
19060906HDL cholesterol1.00E-10Affymetrix and Illumina [~2,600,000] (imputed)12q24.11MMAB,MVKrs2338104
19060906HDL cholesterol4.00E-08Affymetrix and Illumina [~2,600,000] (imputed)1q42.13GALNT2rs4846914
19060906HDL cholesterol1.00E-09Affymetrix and Illumina [~2,600,000] (imputed)9q31.1ABCA1rs1883025
19060906HDL cholesterol1.00E-12Affymetrix and Illumina [~2,600,000] (imputed)11q23.3APOA1, APOC3, APOA4, APOA5rs964184
19060906HDL cholesterol8.00E-23Affymetrix and Illumina [~2,600,000] (imputed)15q22.1LIPCrs10468017
19060906HDL cholesterol4.00E-75Affymetrix and Illumina [~2,600,000] (imputed)16q13CETPrs173539
19060906HDL cholesterol1.00E-08Affymetrix and Illumina [~2,600,000] (imputed)19p13.2ANGPTL4rs2967605
19060906LDL cholesterol2.00E-20Affymetrix and Illumina [~2,600,000] (imputed)2p21ABCG8rs6544713
19060906LDL cholesterol1.00E-11Affymetrix and Illumina [~2,600,000] (imputed)5q33.3TIMD4, HAVCR1rs1501908
19060906LDL cholesterol2.00E-08Affymetrix and Illumina [~2,600,000] (imputed)12q24.31HNF1Ars2650000
19060906LDL cholesterol4.00E-09Affymetrix and Illumina [~2,600,000] (imputed)20q12MAFBrs6102059
19060906LDL cholesterol4.00E-08Affymetrix and Illumina [~2,600,000] (imputed)1p32.3PCSK9rs11206510
19060906LDL cholesterol2.00E-08Affymetrix and Illumina [~2,600,000] (imputed)19p13.11NCAN, CILP2, PBX4rs10401969
19060906LDL cholesterol8.00E-12Affymetrix and Illumina [~2,600,000] (imputed)5q13.3HMGCRrs3846663
19060906LDL cholesterol2.00E-26Affymetrix and Illumina [~2,600,000] (imputed)19p13.2LDLRrs6511720
19060906LDL cholesterol4.00E-27Affymetrix and Illumina [~2,600,000] (imputed)19q13.32APOE, APOC1, APOC4, APOC2rs4420638
19060906LDL cholesterol5.00E-29Affymetrix and Illumina [~2,600,000] (imputed)2p24.1APOBrs515135
19060906LDL cholesterol2.00E-42Affymetrix and Illumina [~2,600,000] (imputed)1p13.3CELSR2, PSRC1, SORT1rs12740374
19060906Triglycerides9.00E-12Affymetrix and Illumina [~2,600,000] (imputed)2p24.1APOBrs7557067
19060906Triglycerides7.00E-11Affymetrix and Illumina [~2,600,000] (imputed)20q13.12PLTPrs7679
19060906Triglycerides3.00E-07Affymetrix and Illumina [~2,600,000] (imputed)1p31.3ANGPTL3rs10889353
19060906Triglycerides4.00E-11Affymetrix and Illumina [~2,600,000] (imputed)19p13.11NCAN,CILP2,PBX4rs17216525
19060906Triglycerides3.00E-15Affymetrix and Illumina [~2,600,000] (imputed)7q11.23MLXIPLrs714052
19060906Triglycerides3.00E-19Affymetrix and Illumina [~2,600,000] (imputed)8q24.13TRIB1rs2954029
19060906Triglycerides2.00E-31Affymetrix and Illumina [~2,600,000] (imputed)2p23.3GCKRrs1260326
19060906Triglycerides2.00E-41Affymetrix and Illumina [~2,600,000] (imputed)8p21.3LPLrs12678919
19060906Triglycerides4.00E-62Affymetrix and Illumina [~2,600,000] (imputed)11q23.3APOA1, APOC3, APOA4, APOA5rs964184
19060906Triglycerides2.00E-14Affymetrix and Illumina [~2,600,000] (imputed)11q12.2FADS1, FADS2, FADS3rs174547
19060906Triglycerides3.00E-08Affymetrix and Illumina [~2,600,000] (imputed)8p23.1XKR6, AMAC1L2rs7819412
19060910HDL cholesterol2.00E-10Illumina [329,091]15q22.1LIPCrs1532085
19060910HDL cholesterol2.00E-07Illumina [329,091]17p13.3Intergenicrs9891572
19060910HDL cholesterol3.00E-08Illumina [329,091]16q22.1LCATrs255049
19060910HDL cholesterol4.00E-08Illumina [329,091]11p11.2NR1H3rs7120118
19060910HDL cholesterol7.00E-29Illumina [329,091]16q13CETPrs3764261
19060910LDL cholesterol2.00E-12Illumina [329,091]1p13.3CELSR2, PSRC1, SORT1rs646776
19060910LDL cholesterol2.00E-07Illumina [329,091]Xq12ARrs5031002
19060910LDL cholesterol5.00E-08Illumina [329,091]19q13.32APO clusterrs157580
19060910LDL cholesterol2.00E-07Illumina [329,091]19p13.2LDLRrs11668477
19060910LDL cholesterol1.00E-07Illumina [329,091]11q12.2FADS1, FADS2rs174546
19060910LDL cholesterol3.00E-11Illumina [329,091]2p24.1APOBrs693
19060910LDL cholesterol2.00E-07Illumina [329,091]1q32.2CR1Lrs4844614
19060910Other metabolic traits3.00E-22Illumina [329,091]1q23.2CRPrs2794520
19060910Other metabolic traits2.00E-08Illumina [329,091]2p24.1APOBrs673548
19060910Other metabolic traits3.00E-07Illumina [329,091]10q23.31PANK1rs11185790
19060910Other metabolic traits6.00E-08Illumina [329,091]11q21MTNR1Brs1447352
19060910Other metabolic traits1.00E-07Illumina [329,091]7p21.2Intergenicrs10244051
19060910Other metabolic traits6.00E-10Illumina [329,091]2q24.3G6PC2, ABCB11rs560887
19060910Other metabolic traits3.00E-11Illumina [329,091]12q24.31LEF1rs2650000
19060910Other metabolic traits4.00E-07Illumina [329,091]1p31.3LEPRrs12753193
19060910Other metabolic traits4.00E-07Illumina [329,091]15q14Intergenicrs2624265
19060910Other metabolic traits5.00E-08Illumina [329,091]8p21.3LPLrs10096633
19060910Other metabolic traits4.00E-10Illumina [329,091]2p23.3GCKRrs1260326
19056611Type 2 diabetes2.00E-17Affymetrix [393,453]16q12.2FTOrs8050136
19056611Type 2 diabetes9.00E-30Affymetrix [393,453]10q25.2TCF7L2rs7903146
19056611Type 2 diabetes5.00E-07Affymetrix [393,453]11p15.1KCNJ11rs5219
19056611Type 2 diabetes0.000007Affymetrix [393,453]8q24.11SLC30A8rs13266634
19056611Type 2 diabetes7.00E-07Affymetrix [393,453]9p21.3CDKN2Brs10811661
19056611Type 2 diabetes6.00E-16Affymetrix [393,453]10q25.2TCF7L2rs7903146
19056611Type 2 diabetes7.00E-07Affymetrix [393,453]6p22.3CDKALrs10946398
19056611Type 2 diabetes1.00E-09Affymetrix [393,453]11p15.1KCNJ11rs5219
19047183Hearing impairmentNSAffymetrix [506,627] (pooled)NRNR
19043545Serum metabolites2.00E-09Affymetrix [187,454]2p14PLEKrs9309413
19043545Serum metabolites4.00E-07Affymetrix [187,454]3q28FGF12rs4453795
19043545Serum metabolites2.00E-07Affymetrix [187,454]7q31.1Intergenicrs10953730
19043545Serum metabolites1.00E-07Affymetrix [187,454]13q31.3GPC5rs17267292
19043545Serum metabolites5.00E-07Affymetrix [187,454]16p13.2A2BP1rs9924951
19043545Serum metabolites2.00E-07Affymetrix [187,454]15q26.1SV2Brs886144
19043545Serum metabolites1.00E-07Affymetrix [187,454]6q25.1C6orf71rs1591830
19043545Serum metabolites3.00E-07Affymetrix [187,454]6q12Intergenicrs9354308
19043545Serum metabolites1.00E-07Affymetrix [187,454]3p25.3ATP2B2rs6807064
19043545Serum metabolites1.00E-07Affymetrix [187,454]6q26PARK2rs992037
19043545Serum metabolites3.00E-09Affymetrix [187,454]10p11.21ANKRD30Ars1148259
19043545Serum metabolites3.00E-07Affymetrix [187,454]12q24.21Intergenicrs2194980
19043545Serum metabolites2.00E-07Affymetrix [187,454]4q13.1Intergenicrs10517480
19043545Serum metabolites5.00E-07Affymetrix [187,454]3q22.3Intergenicrs1382269
19043545Serum metabolites5.00E-08Affymetrix [187,454]11q12.2FADS1rs174548
19043545Serum metabolites1.00E-07Affymetrix [187,454]15q22.1LIPCrs4775041
18957941Personality dimensions9.00E-07Affymetrix [362,129]19q13.31ZNF180rs644148
18957941Personality dimensions0.000002Affymetrix [362,129]4q12CLOCKrs6832769
18957941Personality dimensions0.000006Affymetrix [362,129]Xp11.3FUNDC1rs6610953
18957941Personality dimensions0.000003Affymetrix [362,129]2p22.1THUMPD2rs2540226
18957941Personality dimensions0.000008Affymetrix [362,129]19q13.31ZNF180rs644148
19030899Height0.000002Affymetrix [281,533]9q22.23ZNP510rs10816533
19023125Brain imaging in schizophrenia (interaction)0.000004Illumina [302,783]3p12.3ROBO2, ROBO1rs9836484
19023125Brain imaging in schizophrenia (interaction)9.00E-08Illumina [302,783]5q23.2CTXN3, SLC12A2rs245201
19023125Brain imaging in schizophrenia (interaction)0.000005Illumina [302,783]14q32.32TRAF3rs10133111
19023125Brain imaging in schizophrenia (interaction)0.000004Illumina [302,783]2q37.3GPC1rs1574192
19023125Brain imaging in schizophrenia (interaction)0.000006Illumina [302,783]3q26.2TNIKrs2088885
19023125Brain imaging in schizophrenia (interaction)0.000009Illumina [302,783]6q16.2POU3F2rs9491640
19011631Colorectal cancer5.00E-09Illumina [up to 548,586]19q13.11RHPN2rs10411210
19011631Colorectal cancer2.00E-10Illumina [up to 548,586]20p12.3Intergenicrs961253
19011631Colorectal cancer1.00E-08Illumina [up to 548,586]16q22.1CDH1rs9929218
19011631Colorectal cancer8.00E-10Illumina [up to 548,586]14q22.2BMP4rs4444235
19010793Brain lesion load0.000007Illumina [551,642]19p13.11CPAMD8rs11666377
19010793Brain lesion load0.000007Illumina [551,642]6q25.3IGF2Rrs6917747
19010793Brain lesion load0.000006Illumina [551,642]14q12NUBPLrs2039485
19010793Brain lesion load0.000004Illumina [551,642]2q37.1CHRNDrs2602397
19010793Multiple sclerosis0.000002Illumina [551,642]12q12PDZRN4rs1458175
19010793Multiple sclerosis0.000003Illumina [551,642]3q23SLC25A36rs908821
19010793Multiple sclerosis8.00E-07Illumina [551,642]20p13C20orf46rs397020
19010793Multiple sclerosis0.000003Illumina [551,642]9p22.2SH3GL2rs1755289
19010793Multiple sclerosis0.000009Illumina [551,642]2p25.1DDEF2rs1109670
19010793Multiple sclerosis0.000002Illumina [551,642]8p23.2CSMD1rs1529316
19010793Multiple sclerosis0.000001Illumina [551,642]13q31.3GPC5rs9523762
19010793Multiple sclerosis0.000008Illumina [551,642]4q35.1MGC45800rs7672826
19010793Multiple sclerosis0.000007Illumina [551,642]2q14.2EN1rs651477
19010793Multiple sclerosis0.000008Illumina [551,642]3q24ZIC1rs1841770
19010793Multiple sclerosis (age of onset)0.000004Illumina [551,642]18q21.31WDR7rs1557351
19010793Multiple sclerosis (age of onset)0.000003Illumina [551,642]8q13.3KCNB2rs2116078
19010793Multiple sclerosis (age of onset)0.000007Illumina [551,642]5q33.2SGCDrs4704970
19010793Multiple sclerosis (age of onset)0.000002Illumina [551,642]11q14.2RAB38rs1386330
19010793Multiple sclerosis (age of onset)0.000006Illumina [551,642]1q25.2C1orf125rs12047808
19010793Multiple sclerosis (age of onset)0.000003Illumina [551,642]7q22.1RELNrs17157903
19010793Multiple sclerosis (age of onset)0.000005Illumina [551,642]9q21.13RFKrs2842483
19010793Multiple sclerosis (age of onset)0.000008Illumina [551,642]2q21.2FLJ34870rs1437898
19010793Multiple sclerosis (severity)0.000006Illumina [551,642]6p23JARID2rs6941421
19010793Multiple sclerosis (severity)0.000006Illumina [551,642]16q22.3C16orf47rs7191888
19010793Multiple sclerosis (severity)0.000006Illumina [551,642]11q23.3MGC13125rs180358
19010793Multiple sclerosis (severity)0.000004Illumina [551,642]4q13.2CENPC1rs10518025
19010793Multiple sclerosis (severity)0.000004Illumina [551,642]7p21.3C1GALT1rs10259085
19010793Multiple sclerosis (severity)0.000009Illumina [551,642]19p13.2ACP5rs7253363
19010793Multiple sclerosis (severity)0.000009Illumina [551,642]18q22.3CBLN2rs337718
19010793Multiple sclerosis (severity)0.000004Illumina [551,642]19q13.42NLRP11rs299175
19010793Multiple sclerosis (severity)0.000002Illumina [551,642]4q28.3LOC132321rs1478091
19010793Multiple sclerosis (severity)0.000002Illumina [551,642]3q25.32FLJ16641rs12638253
19010793Multiple sclerosis (severity)0.000006Illumina [551,642]7q31.2METrs10243024
19010793Normalized brain volume0.000004Illumina [551,642]12p11.21BICD1rs261902
19010793Normalized brain volume0.000008Illumina [551,642]10p11.23SVILrs1927457
19010793Normalized brain volume0.000008Illumina [551,642]10q25.2MXI1rs716595
19010793Normalized brain volume0.000007Illumina [551,642]6q21FOXO3rs9480865
19010793Normalized brain volume0.000009Illumina [551,642]5q35.1KCNIP1rs11957313
18997785Multiple sclerosis3.00E-10Affymetrix [~250,000]1p36.22KIF1Brs10492972
18997786Intracranial aneurysm4.00E-08Illumina [289,271]2q33.1BOLL, PLCL1rs700651
18997786Intracranial aneurysm1.00E-10Illumina [289,271]9q21.3CDKN2A, CDKN2Brs1333040
18997786Intracranial aneurysm1.00E-10Illumina [289,271]8q11.23SOX17rs10958409
18997786Intracranial aneurysm2.00E-09Illumina [289,271]8q11.23-q12.1SOX17rs9298506
19009022Nicotine dependenceNSAffymetrix [~600,00] (pooled)NRNR
18985386Parkinson disease (familial)7.00E-07Illumina [328,189]4p16.3GAK, DGKQrs1564282
18987618Amyotrophic lateral sclerosis0.000003Illumina [287,522]7q36.2DPP6rs10260404
18980221Attention-deficit/hyperactivity disorderNSPerlegen [438,784]NRNR
18978792Type 1 diabetes0.000004Affymetrix [up to 335,565]2p23.3Intergenicrs2165738
18978792Type 1 diabetes5.00E-12Affymetrix [up to 335,565]6q15BACH2rs11755527
18978792Type 1 diabetes3.00E-15Affymetrix [up to 335,565]15q25.1CTSHrs3825932
18978792Type 1 diabetes1.00E-40Affymetrix [up to 335,565]1p13.2PTPN22rs6679677
18978792Type 1 diabetes9.00E-08Affymetrix [up to 335,565]18p11.21PTPN2rs2542151
18978792Type 1 diabetes7.00E-13Affymetrix [up to 335,565]16p13.13CLEC16Ars12708716
18978792Type 1 diabetes3.00E-16Affymetrix [up to 335,565]12q13.2ERBB3rs2292239
18978792Type 1 diabetes6.00E-18Affymetrix [up to 335,565]12q24.13C12orf30rs17696736
18978792Type 1 diabetes0.000002Affymetrix [up to 335,565]10p15.1IL2RArs12251307
18978792Type 1 diabetes6.00E-129Affymetrix [up to 335,565]6p21.32HLArs9272346
18978792Type 1 diabetes8.00E-11Affymetrix [up to 335,565]2q33.2CTLA4rs3087243
18978792Type 1 diabetes2.00E-08Affymetrix [up to 335,565]22q13.1C1QTNF6rs229541
18978792Type 1 diabetes4.00E-09Affymetrix [up to 335,565]10p15.1PRKCQrs947474
18978792Type 1 diabetes0.000003Affymetrix [up to 335,565]16p13.13C16orf75, PRM3, TNP2rs416603
18978790Lung cancer0.000004Illumina [315,194]5p15.33TERT, CLPTM1rs402710
18978790Lung cancer1.00E-15Illumina [315,194]15q25.1Intergenicrs1051730
18978787Lung cancer5.00E-10Illumina [223,891]6p21.33BAT3,MSH5rs3117582
18978787Lung cancer8.00E-09Illumina [223,891]5p15.33CLPTM1Lrs401681
18978787Lung cancer8.00E-12Illumina [223,891]15q25.1NRrs8042374
18976728Alzheimer's disease0.000002Affymetrix [484,522]14q31.2Intergenicrs11159647
18976728Alzheimer's disease0.000006Affymetrix [484,522]19q13.33CD33rs3826656
18951430Attention-deficit/hyperactivity disorder and conduct disorder0.000009Perlegen [378,332]1q25.3RGL1, GLT25D2rs10797919
18951430Attention-deficit/hyperactivity disorder and conduct disorder0.000005Perlegen [378,332]14q12Intergenicrs1951082
18951430Attention-deficit/hyperactivity disorder and conduct disorder0.000007Perlegen [378,332]12q15C12orf28rs789560
18951430Attention-deficit/hyperactivity disorder and conduct disorder0.000002Perlegen [378,332]4q13.3AMOTL1, CWC15, JMJD2Drs10831284
18951430Attention-deficit/hyperactivity disorder and conduct disorder0.000009Perlegen [378,332]10p15.2PITRM1rs2764980
18951430Attention-deficit/hyperactivity disorder and conduct disorder0.000006Perlegen [378,332]9p24.1PTPRDrs10815798
18951430Attention-deficit/hyperactivity disorder and conduct disorder0.000005Perlegen [378,332]8q22.3YWHAZrs931812
18951430Attention-deficit/hyperactivity disorder and conduct disorder0.000008Perlegen [378,332]5q31.1C5orf15rs1644305
18951430Attention-deficit/hyperactivity disorder and conduct disorder0.000008Perlegen [378,332]2q33.1FLJ39061, FZD7rs1521882
18951430Attention-deficit/hyperactivity disorder and conduct disorder0.000007Perlegen [378,332]2p12Intergenicrs7595103
18951430Attention-deficit/hyperactivity disorder and conduct disorder0.000004Perlegen [378,332]2p22.3Intergenicrs6733379
18951430Attention-deficit/hyperactivity disorder and conduct disorder0.000008Perlegen [378,332]1q23.1ETV3L, ETV3rs6427356
18951430Attention-deficit/hyperactivity disorder and conduct disorder0.000009Perlegen [378,332]1p35.2Intergenicrs2180233
18951430Attention-deficit/hyperactivity disorder and conduct disorder0.000002Perlegen [378,332]21q21.1Intergenicrs2826340
18951430Attention-deficit/hyperactivity disorder and conduct disorder0.000007Perlegen [378,332]16q23.2PKD1L2, C16orf46rs4889240
18951430Attention-deficit/hyperactivity disorder and conduct disorder0.000007Perlegen [378,332]16q22.3PKD1L3, KIAA0174, DHODHrs16973500
18951430Attention-deficit/hyperactivity disorder and conduct disorder0.000006Perlegen [378,332]18q21.31ATP8B1rs7236632
18951430Attention-deficit/hyperactivity disorder and conduct disorder0.000004Perlegen [378,332]1q42.13LOC729257rs701157
18951430Attention-deficit/hyperactivity disorder and conduct disorder0.000006Perlegen [378,332]16q21Intergenicrs1381102
18951430Attention-deficit/hyperactivity disorder and conduct disorder0.000009Perlegen [378,332]10p14A2BP1rs1291846
18951430Attention-deficit/hyperactivity disorder and conduct disorder0.000004Perlegen [378,332]15q26.2SPATA8rs4533251
18951430Attention-deficit/hyperactivity disorder and conduct disorder0.000005Perlegen [378,332]11q24.2KIRREL3rs1557488
18951430Attention-deficit/hyperactivity disorder and conduct disorder0.000005Perlegen [378,332]7q31.1FLJ31818, GPR85rs10229603
18951430Attention-deficit/hyperactivity disorder and conduct disorder0.000004Perlegen [378,332]12q21.2PAWRrs7297018
18951430Attention-deficit/hyperactivity disorder and conduct disorder0.000001Perlegen [378,332]13q33.3LIG4, ABHD13rs10492664
18951430Attention-deficit/hyperactivity disorder and conduct disorder0.000009Perlegen [378,332]13q12.2GSX1, PDX1rs9512900
18952825Height9.00E-10Illumina [NR]7p15.1JAZF1rs1635852
18941528Multiple sclerosis9.00E-11Affymetrix [428,867] (pooled)6p21.32HLA-DRB1rs3129934
18849994Male-pattern baldness3.00E-15Illumina [531,695]20p11.22PAX1, BQ013595, BE789145rs2180439
18849991Male-pattern baldness1.00E-14Affymetrix [370,102]20p11.22PAX1rs1160312
18849991Male-pattern baldness5.00E-11Affymetrix [370,102]Xq12ARrs6625163
18849993Cutaneous basal cell carcinoma4.00E-12Illumina [304,083]1p36.13PADI4, PADI6,RCC2, ARHGEF10Lrs7538876
18849993Cutaneous basal cell carcinoma6.00E-12Illumina [304,083]1q42.13RHOUrs801114
18940312Plasma levels of liver enzymes2.00E-08Affymetrix and Illumina [up to 496,032]10q24.2qCPN1, CHUK, ERLIN1rs11597390
18940312Plasma levels of liver enzymes2.00E-10Affymetrix and Illumina [up to 496,032]12q24.2HNF1A, C12orf27, C12orf43rs1169313
18940312Plasma levels of liver enzymes7.00E-10Affymetrix and Illumina [up to 496,032]10q21.2REEP3rs10761779
18940312Plasma levels of liver enzymes8.00E-21Affymetrix and Illumina [up to 496,032]9q34.2ADAMTS13rs4962153
18940312Plasma levels of liver enzymes1.00E-11Affymetrix and Illumina [up to 496,032]6p22.2GPLD1rs9467160
18940312Plasma levels of liver enzymes4.00E-11Affymetrix and Illumina [up to 496,032]22q11.23GGT1, C22orf36rs4820599
18940312Plasma levels of liver enzymes2.00E-30Affymetrix and Illumina [up to 496,032]9p34.2ABOrs657152
18940312Plasma levels of liver enzymes7.00E-15Affymetrix and Illumina [up to 496,032]1p36.12NBPF3, ALPL, RAP1GAPrs1780324
18940312Plasma levels of liver enzymes5.00E-10Affymetrix and Illumina [up to 496,032]10q24.31JMJD1Crs12355784
18940312Plasma levels of liver enzymes8.00E-16Affymetrix and Illumina [up to 496,032]22q13.31PNPLA3, SAMM50rs2281135
18940312Plasma levels of liver enzymes0.000004Affymetrix and Illumina [up to 496,032]10q21.3POU2F1rs9803659
18840781Type 1 diabetes1.00E-06Illumina [up to 1,000,000]6q15BACH2rs3757247
18840781Type 1 diabetes2E-06Illumina [up to 1,000,000]1p22.3EDG7rs1983853
18840781Type 1 diabetes0.000003Illumina [up to 1,000,000]9p24.2GLIS3rs10758593
18840781Type 1 diabetes2.00E-08Illumina [up to 1,000,000]21q22.3UBASH3Ars9976767
18840781Type 1 diabetes4E-06Illumina [up to 1,000,000]15q14RASGRP1rs8035957
18846501Attention-deficit/hyperactivity disorder symptoms (interaction)0.000002Perlegen [429,981]13q12.3Intergenicrs1161463
18846501Attention-deficit/hyperactivity disorder symptoms (interaction)0.000008Perlegen [429,981]3q27.2Intergenicrs10049246
18846501Attention-deficit/hyperactivity disorder symptoms (interaction)0.000008Perlegen [429,981]14q24.3Intergenicrs2360997
18846501Attention-deficit/hyperactivity disorder symptoms (interaction)9.00E-07Perlegen [429,981]11q21PIWIL4rs2212361
18846501Attention-deficit/hyperactivity disorder symptoms (interaction)0.000009Perlegen [429,981]8p23.2Intergenicrs4875598
18846501Attention-deficit/hyperactivity disorder symptoms (interaction)0.000008Perlegen [429,981]21q21.1Intergenicrs2825388
18846501Attention-deficit/hyperactivity disorder symptoms (interaction)0.000002Perlegen [429,981]6p21.2KIF6rs4714261
18846501Conduct disorder (interaction)0.000005Perlegen [429,901)2p21Intergenicrs719593
18846501Conduct disorder (interaction)0.000007Perlegen [429,901)18q12.3Intergenicrs17664267
18846501Conduct disorder (interaction)0.000007Perlegen [429,901)1q22RIT1rs2282301
18846501Conduct disorder (interaction)0.000006Perlegen [429,901)10q22.3Intergenicrs2395528
18846501Conduct disorder (interaction)0.000006Perlegen [429,901)3p25.3SLC6A1rs9990174
18846501Conduct disorder (interaction)0.000006Perlegen [429,901)8p23.1MFHAS1rs332034
18846501Conduct disorder (interaction)0.000003Perlegen [429,901)4q23ADH1Crs1789891
18846501Conduct disorder (interaction)0.000003Perlegen [429,901)16p13.3A2BP1rs6500744
18846501Conduct disorder (interaction)0.000002Perlegen [429,901)5q21.1Intergenicrs13188771
18846501Conduct disorder (interaction)0.000009Perlegen [429,901)11q23.2ZBTB16rs17116334
18846501Conduct disorder (interaction)0.000008Perlegen [429,901)2p22.2Intergenicrs604381
18846501Conduct disorder (interaction)0.000008Perlegen [429,901)17q22Intergenicrs8073783
18846501Conduct disorder (interaction)0.000007Perlegen [429,901)4q22.1PPM1Krs893971
18846501Conduct disorder (interaction)0.000009Perlegen [429,901)6p15Intergenicrs16880441
18846501Conduct disorder (interaction)0.000007Perlegen [429,901)15q26.2Intergenicrs4321143
18836448Ulcerative colitis6.00E-18Affymetrix [355,262]6p21.32HLA-DRA, BTNL2rs9268877
18836448Ulcerative colitis1.00E-12Affymetrix [355,262]1q32.1IL10rs3024505
18834626Serum urate3.00E-60Affymetrix and Illumina [up to 530,683]4q22.1ABCG2rs2231142
18834626Serum urate0Affymetrix and Illumina [up to 530,683]4p16.1SLC2A9rs16890979
18834626Serum urate4.00E-29Affymetrix and Illumina [up to 530,683]6p22.2SLC17A3rs1165205
18991354Ischemic stroke2.00E-10Illumina [310,881]4q25NRrs2200733
18835860Idiopathic pulmonary fibrosis3.00E-08Illumina [214,508]5p15.33TERTrs2736100
18823527Alzheimer's disease0.000003Illumina [561,494] (pooled)22q13.33CPT1Brs727153
18823527Alzheimer's disease6.00E-14Illumina [561,494] (pooled)19q13.32PVRL2, TOMM40, APOErs6859
18820697Narcolepsy6.00E-08Affymetrix [249,133]22q13.33CPT1Brs5770917
18821564Attention-deficit/hyperactivity disorder0.000003Affymetrix [319,722]22q13.31Intergenicrs9627183
18821564Attention-deficit/hyperactivity disorder0.000003Affymetrix [319,722]5p15.31Intergenicrs11134178
18802019LDL cholesterol1.00E-08Affymetrix [~500,000]5q13.3HMGCRrs7703051
18802019LDL cholesterol2.00E-07Affymetrix [~500,000]19q13.32APOE, APOC1, APOC4, APOC2rs4420638
18780872Lung cancer1.00E-08Affymetrix [up to 722,376]15q25.1LOC123688, PSMA4, CHRNA3, CHRNA5, CHRNB4rs8034191
18794855Urinary bladder cancer9.00E-12Illumina [302,140]8q24.21MYC, BC042052rs9642880
18794855Urinary bladder cancer1.00E-07Illumina [302,140]3q28TP63rs710521
18794853Rheumatoid arthritis1.00E-07Illumina [818,728] Affymetrix [~340,000] (imputed)1p36.32MMEL1-TNFRSF14rs3890745
18794853Rheumatoid arthritis9.00E-08Illumina [818,728] Affymetrix [~340,000] (imputed)12q13.3KIF5A-PIP4K2Crs1678542
18794853Rheumatoid arthritis8.00E-09Illumina [818,728] Affymetrix [~340,000] (imputed)20q13.12CD40rs4810485
18794853Rheumatoid arthritis6.00E-42Illumina [818,728] Affymetrix [~340,000] (imputed)1p13.2PTPN22rs6679677
18794853Rheumatoid arthritis2.00E-09Illumina [818,728] Affymetrix [~340,000] (imputed)6q23.3OLIG3, TNFIP3rs6920220
18794853Rheumatoid arthritis0Illumina [818,728] Affymetrix [~340,000] (imputed)6p21.32HLA-DRB1rs6457620
18794853Rheumatoid arthritis4E-06Illumina [818,728] Affymetrix [~340,000] (imputed)10p15.1PRKCQrs4750316
18794853Rheumatoid arthritis4E-06Illumina [818,728] Affymetrix [~340,000] (imputed)7q21.2CDK6rs42041
18794853Rheumatoid arthritis3.00E-08Illumina [818,728] Affymetrix [~340,000] (imputed)9p13.3CCL21rs2812378
18760390Hearing impairmentNSAffymetrix [169,154]NRNR
18776929Hip bone size2E-06Affymetrix [306,823]2q33.1PLCL1rs7595412
18776911Plasma level of vitamin B125.00E-17Illumina [528,134]19q13.3FUT2rs492602
18759275Serum uric acid1.00E-11Affymetrix [361,034]4p16.1GLUT9, WDR1rs16890979
18759275Serum uric acid0.000003Affymetrix [361,034]2q31.1NRrs4668338
18759275Serum uric acid2E-06Affymetrix [361,034]13q33.1NRrs4771450
18759275Serum uric acid0.000005Affymetrix [361,034]3p24.3NRrs6442522
18759275Serum uric acid8E-06Affymetrix [361,034]5q31.3NRrs3776331
18759275Serum uric acid0.000006Affymetrix [361,034]20p12.3NRrs6085920
18759275Serum uric acid4E-06Affymetrix [361,034]13q14.11NRrs17065323
18762592Neuroticism7.00E-07Affymetrix [420,287]14q21.3MAMDC1rs12883384
18762592Neuroticism0.000006Affymetrix [420,287]8q24.23AK127771rs2705293
18762592Neuroticism7E-06Affymetrix [420,287]7p21.3NXPH1rs2349775
18758461Chronic lymphocytic leukemia2.00E-20Illumina [345,665]6p25.3IRF4rs872071
18758461Chronic lymphocytic leukemia5.00E-12Illumina [345,665]15q23Intergenicrs7176508
18758461Chronic lymphocytic leukemia4.00E-12Illumina [345,665]11q24.1GRAMD1Brs735665
18758461Chronic lymphocytic leukemia2.00E-10Illumina [345,665]2q13ACOXL,BCL2L11rs17483466
18758461Chronic lymphocytic leukemia4.00E-09Illumina [345,665]19q13.32PRKD2,STRN4rs11083846
18758461Chronic lymphocytic leukemia6.00E-10Illumina [345,665]2q37.1SP140, SP110rs13397985
18758464Inflammatory bowel disease4.00E-10Illumina [NR]16q12.1NOD2rs5743289
18758464Inflammatory bowel disease1.00E-08Illumina [NR]6p21.32HLA-DQA1rs477515
18758464Inflammatory bowel disease7.00E-11Illumina [NR]1p31.3IL23Rrs11209026
18758464Inflammatory bowel disease4.00E-12Illumina [NR]21q22.2PSMG1rs2836878
18758464Inflammatory bowel disease9.00E-15Illumina [NR]20q13.33TNFRSF6Brs2315008
18758464Inflammatory bowel disease3.00E-08Illumina [NR]9q32TNFSF15rs6478109
18729187Lung adenocarcinomaNSIllumina [~318,000] (pooled)NRNR
18846228Serum IgE levels2.00E-20Affymetrix [353,569]1q23.2FCER1Ars2251746
18846228Serum IgE levels4.00E-08Affymetrix [353,569]5q31.1RAD50rs2040704
18711365Bipolar disorder9.00E-09Affymetrix [1,769,948] imputed10q21.2ANK3rs10994336
18711365Bipolar disorder0.000003Affymetrix [1,769,948] imputed9q33.3NRrs4130590
18711365Bipolar disorder4E-06Affymetrix [1,769,948] imputed11q14.1NRrs12290811
18711365Bipolar disorder4.00E-07Affymetrix [1,769,948] imputed15q14C15orf53, RASGRP1rs12899449
18711365Bipolar disorder0.000003Affymetrix [1,769,948] imputed2q11.2Intergenicrs2314398
18711365Bipolar disorder4E-06Affymetrix [1,769,948] imputed6q25.2NRrs17082664
18711365Bipolar disorder4E-06Affymetrix [1,769,948] imputed3p22.3NRrs4380451
18711365Bipolar disorder7.00E-08Affymetrix [1,769,948] imputed12q13.12CACNA1Crs1006737
18711365Bipolar disorder8E-06Affymetrix [1,769,948] imputed10q22.3NRrs703965
18711365Bipolar disorder7E-06Affymetrix [1,769,948] imputed3p26.2NRrs1601875
18711365Bipolar disorder7E-06Affymetrix [1,769,948] imputed18p11.32NRrs7226677
18711365Bipolar disorder0.000006Affymetrix [1,769,948] imputed15q25.1NRrs2278702
18711365Bipolar disorder0.000006Affymetrix [1,769,948] imputed11q24.2NRrs544368
18711365Bipolar disorder0.000006Affymetrix [1,769,948] imputed9q31.3NRrs7042161
18711365Bipolar disorder0.000006Affymetrix [1,769,948] imputed1p21.2NRrs1948368
18711365Bipolar disorder0.000005Affymetrix [1,769,948] imputed3p24.3NRrs11720452
18711365Bipolar disorder0.000005Affymetrix [1,769,948] imputed14q11.2NRrs12436436
18711365Bipolar disorder0.000005Affymetrix [1,769,948] imputed14q13.1NRrs8015959
18711365Bipolar disorder0.000005Affymetrix [1,769,948] imputed3p24.3NRrs3821396
18711365Bipolar disorder4E-06Affymetrix [1,769,948] imputed9p13.3NRrs216345
18711365Bipolar disorder4E-06Affymetrix [1,769,948] imputed15q14NRrs16966460
18685109TP53 carriagePendingAffymetrix [3,884 CNVs]PendingPending
18690218SarcoidosisNSAffymetrix [375,771]NRNR
18677312Systemic lupus erythematosus3.00E-12Affymetrix [313,238]6q23.3TNFAIP3rs5029939
18677312Systemic lupus erythematosus0.000003Affymetrix [313,238]10q11.22c10orf64rs11101442
18677312Systemic lupus erythematosus8E-06Affymetrix [313,238]4q28.3Intergenicrs2313132
18677312Systemic lupus erythematosus8.00E-11Affymetrix [313,238]2q32.3STAT4rs3821236
18677312Systemic lupus erythematosus2E-06Affymetrix [313,238]16p11.2ITGAMrs11150610
18677312Systemic lupus erythematosus2.00E-08Affymetrix [313,238]8p23.1BLKrs2618476
18677312Systemic lupus erythematosus8E-06Affymetrix [313,238]17p12Intergenicrs12949531
18677312Systemic lupus erythematosus0.000009Affymetrix [313,238]2p16.3Intergenicrs17039212
18668548Rheumatoid arthritis0.000006Illumina [299,918]18q23SALL3rs2002842
18668548Rheumatoid arthritis1.00E-09Illumina [299,918]6p21.32HLA-DQA1, HLA-DQA2rs6457617
18677311Schizophrenia2.00E-07Affymetrix [362,532]2q32.1ZNF804Ars1344706
18677311Schizophrenia0.000003Affymetrix [362,532]11p14.1Intergenicrs1602565
18677311Schizophrenia0.000006Affymetrix [362,532]16p13.12Intergenicrs7192086
18660810Restless legs syndrome6.00E-09Affymetrix [208,733]9p24.1PTPRDrs1975197
18660810Restless legs syndrome6.00E-10Affymetrix [208,733]9p23PTPRDrs4626664
18650507Myopathy2.00E-09Illumina [316,184]12p12.1SLCO1B1rs4149056
18723019Crohn's disease and Sarcoidosis (combined)0.000004Affymetrix [83,360]10p12.2C10orf67rs1398024
18615156Treatment response to TNF antagonists2.00E-07Illumina [283,348]20q12MAFBrs6028945
18615156Treatment response to TNF antagonists2E-06Illumina [283,348]7q21.3PON1rs854555
18615156Treatment response to TNF antagonists4E-06Illumina [283,348]4p15.1CENTD1rs437943
18615156Treatment response to TNF antagonists3.00E-07Illumina [283,348]6q26QKIrs10945919
18615156Treatment response to TNF antagonists4E-06Illumina [283,348]2q24.3LASS6rs13393173
18615156Treatment response to TNF antagonists0.000005Illumina [283,348]1p22.3LMO4rs983332
18615156Treatment response to TNF antagonists0.000003Illumina [283,348]20p11.21CST5rs6138150
18615156Treatment response to TNF antagonists5.00E-07Illumina [283,348]9p21.2IFNKrs7046653
18604267Soluble ICAM-15.00E-29Illumina [336,108]9q34.2ABOrs507666
18604267Soluble ICAM-13.00E-10Illumina [336,108]19p13.2ICAM1rs281437
18604267Soluble ICAM-15.00E-25Illumina [336,108]19p13.2ICAM1rs5498
18604267Soluble ICAM-14.00E-47Illumina [336,108]19p13.2ICAM1rs1799969
18601904Subarachnoid aneurysmal hemorrhagePendingIllumina [317,503]PendingPending
18594024Osteonecrosis of the jaw1.00E-06Affymetrix [339,972]10q23.33CYP2C8rs1934951
18591461Response to diuretic therapy0.000006Affymetrix [up to 102,334]12q15LYZ, YEATS4, FRS2rs317689,rs315135,rs7297610
18587394Crohn's disease2.00E-13Affymetrix and Illumina [635,547] (imputed)13q14.11Unknownrs3764147
18587394Crohn's disease7.00E-12Affymetrix and Illumina [635,547] (imputed)17q21.2STAT3rs744166
18587394Crohn's disease2.00E-10Affymetrix and Illumina [635,547] (imputed)6q21Unknownrs7746082
18587394Crohn's disease1.00E-12Affymetrix and Illumina [635,547] (imputed)6q27CCR6rs2301436
18587394Crohn's disease4.00E-13Affymetrix and Illumina [635,547] (imputed)5q33.3IL12Brs10045431
18587394Crohn's disease2.00E-09Affymetrix and Illumina [635,547] (imputed)10p11.21Intergenicrs17582416
18587394Crohn's disease3.00E-09Affymetrix and Illumina [635,547] (imputed)9p24.1JAK2rs10758669
18587394Crohn's disease5.00E-09Affymetrix and Illumina [635,547] (imputed)8q24.13Intergenicrs1551398
18587394Crohn's disease5.00E-09Affymetrix and Illumina [635,547] (imputed)7p12.2Intergenicrs1456893
18587394Crohn's disease9.00E-10Affymetrix and Illumina [635,547] (imputed)6p22.3CDKAL1rs6908425
18587394Crohn's disease1.00E-11Affymetrix and Illumina [635,547] (imputed)1q32.1Intergenicrs11584383
18587394Crohn's disease2.00E-09Affymetrix and Illumina [635,547] (imputed)1q24.3Intergenicrs9286879
18587394Crohn's disease1.00E-09Affymetrix and Illumina [635,547] (imputed)1q23.2ITLN1rs2274910
18587394Crohn's disease1.00E-08Affymetrix and Illumina [635,547] (imputed)1p13.2PTPN22rs2476601
18587394Crohn's disease4.00E-20Affymetrix and Illumina [635,547] (imputed)10q21.2ZNF365rs10995271
18587394Crohn's disease5.00E-17Affymetrix and Illumina [635,547] (imputed)18p11.21PTPN2rs2542151
18587394Crohn's disease3.00E-24Affymetrix and Illumina [635,547] (imputed)16q12.1NOD2rs2066847
18587394Crohn's disease3.00E-16Affymetrix and Illumina [635,547] (imputed)10q24.2NKX2-3rs11190140
18587394Crohn's disease3.00E-10Affymetrix and Illumina [635,547] (imputed)9q32TNFSF15rs4263839
18587394Crohn's disease3.00E-16Affymetrix and Illumina [635,547] (imputed)5q33.1IRGMrs11747270
18587394Crohn's disease2.00E-18Affymetrix and Illumina [635,547] (imputed)5q31.1Intergenicrs2188962
18587394Crohn's disease7.00E-27Affymetrix and Illumina [635,547] (imputed)5p13.1PTGER4rs4613763
18587394Crohn's disease1.00E-12Affymetrix and Illumina [635,547] (imputed)3p21.31MST1rs3197999
18587394Crohn's disease2.00E-32Affymetrix and Illumina [635,547] (imputed)2q37.1ATG16L1rs3828309
18587394Crohn's disease7.00E-63Affymetrix and Illumina [635,547] (imputed)1p31.3IL23Rrs11465804
18587394Crohn's disease1.00E-09Affymetrix and Illumina [635,547] (imputed)21q22.3ICOSLGrs762421
18587394Crohn's disease7.00E-09Affymetrix and Illumina [635,547] (imputed)21q21.1Intergenicrs1736135
18587394Crohn's disease5.00E-09Affymetrix and Illumina [635,547] (imputed)17q12ORMDL3rs2872507
18587394Crohn's disease3.00E-10Affymetrix and Illumina [635,547] (imputed)12q12LRRK2, MUC19rs11175593
18587394Crohn's disease1.00E-09Affymetrix and Illumina [635,547] (imputed)11q13.5C11orf30rs7927894
18576341Juvenile idiopathic arthritis2.00E-10Illumina [524,684]6p21.32HLA-DRB1rs2395148
18451265Fasting plasma glucose4.00E-23Illumina [392,935]2q24.3G6PC2rs560887
18535201Warfarin maintenance dose9.00E-07Illumina [538,629]12p13.33CACNA1Crs216013
18535201Warfarin maintenance dose5.00E-34Illumina [538,629]16p11.2VKORC1rs10871454
18535201Warfarin maintenance dose6.00E-12Illumina [538,629]10q23.33CYP2C9rs4086116
18521185Fasting plasma glucose4.00E-07Illumina [315,635]2q24.3G6PC2,ABCB11rs563694
18519826Smoking cessationNSAffymetrix [~500,000] (pooled)NRNR
18521090Response to iloperidone treatment (PANSS-T score)NSAffymetrix [334,563]NRNR
18521091Response to iloperidone treatment (QT prolongation)2E-06Affymetrix [339,272]14q12NUBPLrs7142881
18521091Response to iloperidone treatment (QT prolongation)0.000003Affymetrix [339,272]18q12.2BRUNOL4rs4799915
18521091Response to iloperidone treatment (QT prolongation)0.000003Affymetrix [339,272]2q31.3CERKLrs993648
18521091Response to iloperidone treatment (QT prolongation)2E-06Affymetrix [339,272]15q26.1SLCO3A1rs3924426
18521091Response to iloperidone treatment (QT prolongation)0.000003Affymetrix [339,272]4q32.3PALLDrs17054392
18521091Response to iloperidone treatment (QT prolongation)2E-06Affymetrix [339,272]10q23.1NRG3rs4933824
18488026Melanoma1.00E-15Illumina [535,150] (pooled)20q11.22CDC91L1rs910873
18488028Blond vs. brown hair4.00E-30Illumina [316,515]11q13.2TPCN2rs35264875
18488028Blue vs. green eyes6.00E-17Illumina [316,515]9p23TYRP1rs1408799
18488028Burning and freckling6.00E-37Illumina [316,515]20q11.22ASIPrs1015362,rs4911414
18488028Freckles8.00E-29Illumina [316,515]20q11.22ASIPrs1015362,rs4911414
18488028Red vs. non-red hair3.00E-09Illumina [316,515]20q11.22ASIPrs1015362,rs4911414
18488028Skin sensitivity to sun2.00E-24Illumina [316,515]20q11.22ASIPrs1015362,rs4911414
18483556Black vs. blond hair color5.00E-11Illumina [528,173]15q13.1Intergenicrs8033165
18483556Black vs. blond hair color2.00E-24Illumina [528,173]15q13.1OCA2rs11855019
18483556Black vs. blond hair color1.00E-17Illumina [528,173]5p13.3MATPrs28777
18483556Black vs. blond hair color6.00E-08Illumina [528,173]6p25.3EXOC2rs6918152
18483556Black vs. blond hair color7.00E-127Illumina [528,173]6p25.3IRF4rs12203592
18483556Black vs. blond hair color4.00E-103Illumina [528,173]15q13.1HERC2rs12913832
18483556Black vs. blond hair color8.00E-21Illumina [528,173]14q32.12SLC24A4rs12896399
18483556Black vs. red hair color2.00E-12Illumina [528,173]15q13.1Intergenicrs8033165
18483556Black vs. red hair color2.00E-23Illumina [528,173]16q24.3MC1Rrs258322
18483556Black vs. red hair color9.00E-14Illumina [528,173]5p13.3MATPrs28777
18483556Black vs. red hair color1.00E-77Illumina [528,173]15q13.1HERC2rs12913832
18483556Black vs. red hair color5.00E-07Illumina [528,173]6p25.3EXOC2rs6918152
18483556Black vs. red hair color9.00E-28Illumina [528,173]6p25.3IRF4rs12203592
18483556Black vs. red hair color6.00E-20Illumina [528,173]15q13.1OCA2rs11855019
18463370Neuroblastoma9.00E-15Illumina [464,934]6p22.3FLJ22536, FLJ44180rs6939340
18464913Protein quantitative trait loci7.00E-40Illumina [496,032]9q34.2ABOrs505922
18464913Protein quantitative trait loci3.00E-07Illumina [496,032]17p13.1SHBGrs6761
18464913Protein quantitative trait loci0.000006Illumina [496,032]1q23.2CRPrs12093699
18464913Protein quantitative trait loci7E-06Illumina [496,032]2q13IL1RNrs6761276
18464913Protein quantitative trait loci0.000006Illumina [496,032]2p15LOC51057rs11683229
18464913Protein quantitative trait loci5.00E-07Illumina [496,032]2p12CTNNA2rs11695685
18464913Protein quantitative trait loci4E-06Illumina [496,032]2q23.1EPC2rs10191411
18464913Protein quantitative trait loci1.00E-06Illumina [496,032]5q35.1DOCK2rs169082
18464913Protein quantitative trait loci3.00E-07Illumina [496,032]6q11.1KHDRBS2rs6455128
18464913Protein quantitative trait loci7.00E-13Illumina [496,032]11q23.1IL18rs2250417
18464913Protein quantitative trait loci2.00E-07Illumina [496,032]22q11.23GGT1rs5751901
18464913Protein quantitative trait loci4.00E-10Illumina [496,032]6q26LPArs7770628
18464913Protein quantitative trait loci4.00E-21Illumina [496,032]17q12CCL4L2rs4796217
18464913Protein quantitative trait loci2.00E-57Illumina [496,032]1q21.3IL6Rrs4129267
18464913Protein quantitative trait loci0.000006Illumina [496,032]10p12.33CACNB2rs7076247
18464913Protein quantitative trait loci8.00E-07Illumina [496,032]9q31.2TMEM38Brs4742971
18464913Protein quantitative trait loci0.000003Illumina [496,032]9q22.2GADD45G,DIRAS2rs2081670
18464913Protein quantitative trait loci0.000006Illumina [496,032]8q24.21FAM49Brs10092658
18464913Protein quantitative trait loci8.00E-07Illumina [496,032]8q21.11GDAP1,PI15rs6472866
18464913Protein quantitative trait loci1.00E-06Illumina [496,032]7p21.3NXPH1rs1285407
18464913Protein quantitative trait loci1.00E-06Illumina [496,032]6q24.3SASH1rs6930337
18464913Protein quantitative trait loci1.00E-06Illumina [496,032]6q23.2EYA4rs9402515
18464913Protein quantitative trait loci2E-06Illumina [496,032]6q22.31GJA1rs4541776
18464913Protein quantitative trait loci1.00E-06Illumina [496,032]12q24.33GPR133rs10466868
18464913Protein quantitative trait loci1.00E-07Illumina [496,032]12q24.11ATP2A2rs11065611
18464913Protein quantitative trait loci1.00E-10Illumina [496,032]12q12PDZRN4,CNTN1rs1880887
18464913Protein quantitative trait loci7.00E-07Illumina [496,032]12p12.3EPS8rs17415853
18464913Protein quantitative trait loci1.00E-06Illumina [496,032]11q24.2KIRREL3rs1939992
18464913Protein quantitative trait loci6.00E-09Illumina [496,032]11q23.3PAFAH1B2rs7112513
18464913Protein quantitative trait loci8E-06Illumina [496,032]11q14.1DLG2rs3885683
18464913Protein quantitative trait loci1.00E-06Illumina [496,032]11p15.5KCNQ1rs2237878
18464913Protein quantitative trait loci0.000003Illumina [496,032]10p11.21FZD8,ANKRD30Ars1779876
18464913Protein quantitative trait loci0.000003Illumina [496,032]18q12.1DSC3rs2729409
18464913Protein quantitative trait loci2.00E-07Illumina [496,032]18q11.2OSBPL1Ars9635963
18464913Protein quantitative trait loci4.00E-07Illumina [496,032]17q25.3C17orf62rs9303029
18464913Protein quantitative trait loci8.00E-09Illumina [496,032]17p12HS3ST3B1rs3848445
18464913Protein quantitative trait loci5.00E-07Illumina [496,032]16q23.2BCM01rs4889294
18464913Protein quantitative trait loci0.000003Illumina [496,032]15q21.1DUTrs11637235
18464913Protein quantitative trait loci5.00E-07Illumina [496,032]15q15.2CDAN1rs16957063
18464913Protein quantitative trait loci4E-06Illumina [496,032]13q12.2SACSrs4770433
18464913Protein quantitative trait loci1.00E-07Illumina [496,032]13q12.11FGF3rs17369571
18464913Protein quantitative trait loci4.00E-07Illumina [496,032]19p13.2ANGPTL6rs8109578
18464913Protein quantitative trait loci4E-06Illumina [496,032]6p21.33HLA-Crs9461688
18464913Protein quantitative trait loci4E-06Illumina [496,032]3p12.3ROBO1rs9834373
18464913Protein quantitative trait loci7E-06Illumina [496,032]2p11.2SH2D6rs7577642
18464913Protein quantitative trait loci1.00E-06Illumina [496,032]2p13.3DYSFrs2900976
18464913Protein quantitative trait loci7.00E-07Illumina [496,032]1q21.1CHD1Lrs4950322
18464913Protein quantitative trait loci2.00E-07Illumina [496,032]1q21.1CHD1Lrs4950322
18464913Protein quantitative trait loci0.000003Illumina [496,032]1p21.1COL11Ars10874639
18463975Breast cancer4.00E-07Affymetrix [200,220]2q37.1GLG1rs10871290
18471798Knee osteoarthritis0.000003Illumina [413,461]1q31.1PTGS2, PLA2G4Ars4140564
18471798Knee osteoarthritis0.000006Illumina [413,461]2q33.3PARD3Brs1207421
18454146Waist circumference and related phenotypes2.00E-09Illumina [308,067]18q21.32MC4Rrs12970134
18454146Waist circumference and related phenotypes1.00E-27Illumina [308,067]16q13CETPrs3764261
18454146Waist circumference and related phenotypes0.000005Illumina [308,067]8p21.3LPLrs2083637
18454146Waist circumference and related phenotypes4.00E-08Illumina [308,067]2p23.3GCKRrs1260326
18454148Body mass index4.00E-08Affymetrix [344,883]16q12.2FTOrs1121980
18454148Body mass index3.00E-15Affymetrix [344,883]18q21.32MC4Rrs17782313
18449908Alzheimer's diseaseNSAffymetrix [469,218]NRNR
18455228Bone mineral density8.00E-10Illumina [314,075]8q24.12TNFRSF11Brs4355801
18455228Bone mineral density6.00E-12Illumina [314,075]11q13.2LRP5rs3736228
18445777Bone mineral density (hip)5.00E-16Illumina [301,019]1p36.12ZBTB40rs7524102
18445777Bone mineral density (hip)3.00E-11Illumina [301,019]8q24.12OPGrs6993813
18445777Bone mineral density (hip)1.00E-06Illumina [301,019]18q21.33RANKrs3018362
18445777Bone mineral density (hip)2.00E-07Illumina [301,019]6q25.1ESR1, C6orf97rs4870044
18445777Bone mineral density (hip)2.00E-08Illumina [301,019]13q14.11RANKLrs9594738
18445777Bone mineral density (hip)5.00E-09Illumina [301,019]6q25.1ESR1rs1038304
18445777Bone mineral density (spine)8.00E-07Illumina [301,019]2p16.2SPTBN1rs11898505
18445777Bone mineral density (spine)2.00E-21Illumina [301,019]13q14.11RANKLrs9594759
18445777Bone mineral density (spine)7.00E-15Illumina [301,019]8q24.12OPGrs6469804
18445777Bone mineral density (spine)4.00E-11Illumina [301,019]6q25.1ESR1, C6orf97rs1038304
18445777Bone mineral density (spine)9.00E-09Illumina [301,019]1p36.12ZBTB40rs7524102
18445777Bone mineral density (spine)1.00E-07Illumina [301,019]6p21.32MHC, C6orf10rs3130340
18445777Bone mineral density (spine)2.00E-11Illumina [301,019]6p25.1ESR1rs4870044
18445777Bone mineral density (spine)2.00E-08Illumina [301,019]6q25.1ESR1, C6orf97rs1999805
18369103SchizophreniaPendingIllumina [~550,000]PendingPending
18439552C-reactive protein2.00E-08Illumina [317,000]12q24.31HNF1Ars1169310
18439552C-reactive protein1.00E-07Illumina [317,000]19q13.32APOErs2075650
18439552C-reactive protein7E-06Illumina [317,000]1q23.2CRPrs11265260
18439548C-reactive protein7.00E-21Illumina [336,108]1p31.3LEPRrs1892534
18439548C-reactive protein1.00E-10Illumina [336,108]12q23.2Unknownrs10778213
18439548C-reactive protein2.00E-08Illumina [336,108]1q21.3IL6Rrs8192284
18439548C-reactive protein6.00E-28Illumina [336,108]1q23.2CRPrs3091244
18439548C-reactive protein9.00E-21Illumina [336,108]19q13.32APOErs769449
18439548C-reactive protein7.00E-15Illumina [336,108]2p23.3GCKRrs780094
18439548C-reactive protein7.00E-17Illumina [336,108]12q24.31HNF1Ars7310409
18403759YKL-40 levels1.00E-13Affymetrix [290,325]1q32.1CHI3L1rs4950928
18391951Height1.00E-27Illumina and Affymetrix [up to 304,226]3q23ZBTB38rs6763931
18391951Height7.00E-15Illumina and Affymetrix [up to 304,226]7p22.2GNA12rs798544
18391951Height5.00E-14Illumina and Affymetrix [up to 304,226]6q24.1GPR126rs3748069
18391951Height2.00E-11Illumina and Affymetrix [up to 304,226]6p24.3BMP6rs12198986
18391951Height3.00E-08Illumina and Affymetrix [up to 304,226]1q24.3DNM3rs678962
18391951Height6.00E-11Illumina and Affymetrix [up to 304,226]2p16.1EFEMP1, PNPT1rs3791679
18391951Height6.00E-10Illumina and Affymetrix [up to 304,226]6p22.1Histone class 1,Butyrophilin genesrs10946808
18391951Height1.00E-08Illumina and Affymetrix [up to 304,226]6p21.31HMGA1, LBHrs1776897
18391951Height1.00E-07Illumina and Affymetrix [up to 304,226]17q22NOG, DGKE, TRIM25, COIL, RISKrs4794665
18391951Height2.00E-09Illumina and Affymetrix [up to 304,226]17q11.2CRLF3, ATAD5, CENTA2, RNF135rs3760318
18391951Height3.00E-08Illumina and Affymetrix [up to 304,226]15q26.3ADAMTS17rs4533267
18391951Height2.00E-16Illumina and Affymetrix [up to 304,226]12q14.3HMGA2rs8756
18391951Height2.00E-08Illumina and Affymetrix [up to 304,226]9q31.2ZNF462rs4743034
18391951Height5.00E-08Illumina and Affymetrix [up to 304,226]8q21.11PXMP3, ZFHX4rs7846385
18391951Height7.00E-08Illumina and Affymetrix [up to 304,226]8q12.1PLAG1, MOS, CHCHD7,RDHE2, RPS20,LYN, TGS1, PENKrs10958476
18391951Height1.00E-08Illumina and Affymetrix [up to 304,226]7q21.2CDK6, PEX1, GATAD1, ERVWE1rs2282978
18391951Height4.00E-08Illumina and Affymetrix [up to 304,226]6p21.31ANKS1A, TCP11, ZNF76, DEF6,SCUBE3rs4713858
18391951Height2.00E-07Illumina and Affymetrix [up to 304,226]9q32COL27A1rs946053
18391951Height9.00E-07Illumina and Affymetrix [up to 304,226]9q22.1SPIN1, CCRKrs2814828
18391951Height0.000006Illumina and Affymetrix [up to 304,226]6q22.33-6q23.1L3MBTL3, SAMD3rs6899976
18391951Height6.00E-07Illumina and Affymetrix [up to 304,226]6q22.32C6orf173rs1490388
18391951Height4E-06Illumina and Affymetrix [up to 304,226]6q21PPIL6, CD164, SMPD2,MNICAL1,ZBTB24rs9487094
18391951Height8.00E-07Illumina and Affymetrix [up to 304,226]6q21LIN28B, HACE1, BVES, POPDC3rs314268
18391951Height8E-06Illumina and Affymetrix [up to 304,226]6p12.3SUPT3H, RUNX2rs9395066
18391951Height7.00E-07Illumina and Affymetrix [up to 304,226]6p22.3NUP153, CAP2, KIF13Ars12199222
18391951Height8E-06Illumina and Affymetrix [up to 304,226]5q31.1PITX1, PCBD2, CATSPER3, TXNDC15,DDX46, CAMLGrs31198
18391951Height1.00E-06Illumina and Affymetrix [up to 304,226]19p13.2ADAMTS10, MYO1F, PRAM1, OR2Z1rs7249094
18391951Height7.00E-07Illumina and Affymetrix [up to 304,226]17q23.3MAP3K3, WDR68, LYK5, MT1Frs7209435
18391951Height8.00E-07Illumina and Affymetrix [up to 304,226]16q24.1ZDHHC7, CRISPLD2, USP10rs2326458
18391951Height9.00E-07Illumina and Affymetrix [up to 304,226]15q25.2ADAMTSL3, SH3GL3rs2554380
18391951Height8E-06Illumina and Affymetrix [up to 304,226]13q14.3DLEU7rs1239947
18391951Height2.00E-07Illumina and Affymetrix [up to 304,226]12q22SOCS2, MRPL42, CRADD, UBE2Nrs3825199
18391951Height0.000003Illumina and Affymetrix [up to 304,226]12q15LYZ,YEATS4,FRS2,CPSF6,CCT2,LRRC10rs11177669
18391951Height2E-06Illumina and Affymetrix [up to 304,226]12p12.2PDE3A, SLCO1C1, SLCO1B3rs11611208
18391951Height2E-06Illumina and Affymetrix [up to 304,226]12p13.2ETV6rs2187642
18391951Height1.00E-10Illumina and Affymetrix [up to 304,226]14q23.12TRIP11, FBLN5, ATXN3, CPSF2rs7153027
18391951Height8.00E-07Illumina and Affymetrix [up to 304,226]20q11.22UQCC, GDF5, CEP250, EIF6, MMP24rs6088792
18391951Height0.000003Illumina and Affymetrix [up to 304,226]Xq21.1ITM2Ars1474563
18391951Height0.000006Illumina and Affymetrix [up to 304,226]22q11.23BCR, GNAZ, RTDR1, IGLL1rs5751614
18391951Height2E-06Illumina and Affymetrix [up to 304,226]4q21.21BMP3, PRKG2, RASGEF1Brs710841
18391951Height7E-06Illumina and Affymetrix [up to 304,226]3q26.2GOLIM4, SERPINI1rs4345115
18391951Height1.00E-06Illumina and Affymetrix [up to 304,226]2q37.1NPPC, DIS3L2, COPS7B, PDE6D, PTMArs749052
18391951Height1.00E-06Illumina and Affymetrix [up to 304,226]2q35IHH, CRYBA2, FEV, SLC23A3, TUBA1rs1052483
18391951Height8.00E-07Illumina and Affymetrix [up to 304,226]2p23.3ADCY3, RBJ, POMC, DNMT3A, DTNBrs6733301
18391951Height2.00E-08Illumina and Affymetrix [up to 304,226]20p12.3BMP2rs967417
18391951Height4.00E-09Illumina and Affymetrix [up to 304,226]18q11.2CABLES1, RBBP8, C18orf45rs4800148
18391951Height6.00E-08Illumina and Affymetrix [up to 304,226]17q23.2BCAS3, NACA2, TBX2, TBX4rs757608
18391951Height3.00E-08Illumina and Affymetrix [up to 304,226]6p21.32HLA class IIIrs185819
18391951Height1.00E-10Illumina and Affymetrix [up to 304,226]4p15.32LCORL, NCAPGrs6830062
18391951Height8.00E-09Illumina and Affymetrix [up to 304,226]1q25.3C1orf19,GLT25D2rs2274432
18391951Height1.00E-10Illumina and Affymetrix [up to 304,226]1q21.2Histone class 2A,MTMR11, SV2A, SF3B4rs11205277
18391951Height1.00E-11Illumina and Affymetrix [up to 304,226]4q31.22HHIPrs1812175
18391950Height8.00E-22Affymetrix and Illumina [2,260,683] (imputed)3q23ZBTB38rs724016
18391950Height4.00E-17Affymetrix and Illumina [2,260,683] (imputed)6q22.1HIST1H1Drs10946808
18391950Height1.00E-11Affymetrix and Illumina [2,260,683] (imputed)4q31.22HHIPrs1492820
18391950Height2E-06Affymetrix and Illumina [2,260,683] (imputed)17q22ANKFN1rs12449568
18391950Height1.00E-06Affymetrix and Illumina [2,260,683] (imputed)9q33.1PAPPArs7869550
18391950Height8.00E-07Affymetrix and Illumina [2,260,683] (imputed)9q34.11FUBP3rs7466269
18391950Height3.00E-07Affymetrix and Illumina [2,260,683] (imputed)7q36.3WDR60rs2730245
18391950Height4.00E-07Affymetrix and Illumina [2,260,683] (imputed)7q21.2CDK6rs2040494
18391950Height4.00E-07Affymetrix and Illumina [2,260,683] (imputed)8q12.1CHCHD7,RDHE2rs9650315
18391950Height6.00E-08Affymetrix and Illumina [2,260,683] (imputed)15q25.2SH3GL3,ADAMTSL3rs2562784
18391950Height3.00E-08Affymetrix and Illumina [2,260,683] (imputed)19p13.3DOT1Lrs12986413
18391950Height1.00E-08Affymetrix and Illumina [2,260,683] (imputed)6q21LIN28Brs314277
18391950Height1.00E-16Affymetrix and Illumina [2,260,683] (imputed)20q11.22GDF5,UQCCrs6060369
18391950Height3.00E-20Affymetrix and Illumina [2,260,683] (imputed)12q14.3HMGA2rs1042725
18391950Height8E-06Affymetrix and Illumina [2,260,683] (imputed)14q13.3NKX2-1rs17104630
18391950Height0.000005Affymetrix and Illumina [2,260,683] (imputed)16p13.3RAB40Crs763014
18391950Height6.00E-10Affymetrix and Illumina [2,260,683] (imputed)14q32.12TRIP11,ATXN3rs8007661
18391950Height2.00E-18Affymetrix and Illumina [2,260,683] (imputed)6q24.3GPR126rs4896582
18391952Height2.00E-24Affymetrix [402,951]3q23ZBTB38rs6440003
18391952Height4.00E-11Affymetrix [402,951]9q22.32PTCH1rs10512248
18391952Height7.00E-08Affymetrix [402,951]3q22.2ANAPC13,CEP63rs10935120
18391952Height2.00E-08Affymetrix [402,951]2q35IHHrs6724465
18391952Height2.00E-08Affymetrix [402,951]15q25.2ADAMTSL3rs10906982
18391952Height2.00E-08Affymetrix [402,951]1p34.2SCMH1rs6686842
18391952Height7.00E-09Affymetrix [402,951]13q14.3DLEU7rs3116602
18391952Height5.00E-09Affymetrix [402,951]1q42.13ZNF678rs1390401
18391952Height2.00E-09Affymetrix [402,951]4q31.22HHIPrs6854783
18391952Height6.00E-10Affymetrix [402,951]12q22SOCS2rs11107116
18391952Height4.00E-11Affymetrix [402,951]1p12SPAG17rs12735613
18391952Height3.00E-07Affymetrix [402,951]18q21.1DYMrs8099594
18391952Height8.00E-08Affymetrix [402,951]15q26.1ACANrs8041863
18391952Height4.00E-12Affymetrix [402,951]6p21.31C6orf106rs2814993
18391952Height2.00E-13Affymetrix [402,951]4p15.32LCORLrs16896068
18391952Height2.00E-17Affymetrix [402,951]20q11.22GDF5rs6060373
18391952Height5.00E-13Affymetrix [402,951]6q22.32LOC387103rs4549631
18391952Height2.00E-12Affymetrix [402,951]2p16.1EFEMP1rs3791675
18391952Height8.00E-23Affymetrix [402,951]7q21.2CDK6rs2282978
18391952Height3.00E-18Affymetrix [402,951]12q14.3HMGA2rs1042725
18369459Psoriasis2E-06Illumina [305,983]13q13COG6rs7993214
18369459Psoriasis2.00E-26Illumina [305,983]6p21.33HLA-Crs2395029
18369459Psoriasis2.00E-39Illumina [305,983]6p21.33HLA-Crs10484554
18385676Lung cancer3.00E-18Illumina [317,498]15q25.1CHRNA3, CHRNA5, PSMA4, LOC123688rs8034191
18385676Lung cancer7E-06Illumina [317,498]1q23.2CRPrs2808630
18385676Lung cancer8E-06Illumina [317,498]3q28IL1RAPrs7626795
18385738Lung cancer5.00E-20Illumina [310,023]15q25.1CHRNA3,CHRNA5, CHRNB4, PSMA4, LOC123688rs8034191
18385739Nicotine dependence6.00E-20Illumina [306,207]15q25.1CHRNA3,CHRNA5,CHRNB4rs1051730
18372901Colorectal cancer9.00E-26Illumina [541,628]8q24.21POU5FIP1, HsG57825, DQ515897rs7014346
18372901Colorectal cancer8.00E-28Illumina [541,628]18q21.1SMAD7rs4939827
18372901Colorectal cancer6.00E-10Illumina [541,628]11q23.1Intergenicrs3802842
18372905Colorectal cancer3.00E-13Illumina [547,647]10p14Intergenicrs10795668
18372905Colorectal cancer3.00E-18Illumina [547,647]8q23.3EIF3Hrs16892766
18372905Colorectal cancer5.00E-07Illumina [547,647]15q13.3Intergenicrs4779584
18372905Colorectal cancer2E-06Illumina [547,647]18q21.1SMAD7rs4939827
18372905Colorectal cancer7.00E-11Illumina [547,647]8q24.21Intergenicrs6983267
18372903Type 2 diabetes5.00E-14Affymetrix and Illumina [2,202,892] (imputed)7p15.1JAZF1rs864745
18372903Type 2 diabetes1.00E-08Affymetrix and Illumina [2,202,892] (imputed)3p14.1ADAMTS9rs4607103
18372903Type 2 diabetes2.00E-07Affymetrix and Illumina [2,202,892] (imputed)12q13.2DCDrs1153188
18372903Type 2 diabetes2.00E-07Affymetrix and Illumina [2,202,892] (imputed)3p25.2SYN2, PPARGrs17036101
18372903Type 2 diabetes1.00E-11Affymetrix and Illumina [2,202,892] (imputed)6p22.3CDKAL1rs6931514
18372903Type 2 diabetes7.00E-08Affymetrix and Illumina [2,202,892] (imputed)10q23.33HHEXrs5015480
18372903Type 2 diabetes7E-06Affymetrix and Illumina [2,202,892] (imputed)16q12.2FTOrs8050136
18372903Type 2 diabetes3.00E-23Affymetrix and Illumina [2,202,892] (imputed)10q25.2TCF7L2rs7903146
18372903Type 2 diabetes4.00E-07Affymetrix and Illumina [2,202,892] (imputed)11p15.1KCNJ11rs5215
18372903Type 2 diabetes2.00E-07Affymetrix and Illumina [2,202,892] (imputed)9p21.3CDKN2A,CDKN2Brs7020996
18372903Type 2 diabetes8.00E-08Affymetrix and Illumina [2,202,892] (imputed)3q27.2IGF2BP2rs4402960
18372903Type 2 diabetes4E-06Affymetrix and Illumina [2,202,892] (imputed)6p21.1VEGFArs9472138
18372903Type 2 diabetes4.00E-08Affymetrix and Illumina [2,202,892] (imputed)1p12NOTCH2, ADAM30rs10923931
18372903Type 2 diabetes1.00E-09Affymetrix and Illumina [2,202,892] (imputed)2p21THADArs7578597
18372903Type 2 diabetes1.00E-10Affymetrix and Illumina [2,202,892] (imputed)10p13CDC123,CAMK1Drs12779790
18372903Type 2 diabetes1.00E-09Affymetrix and Illumina [2,202,892] (imputed)12q21.1TSPAN8,LGR5rs7961581
18360741Environmental confusion in the homeNSAffymetrix [117,062] (pooled)NRNR
18364390Psoriasis1.00E-09Illumina [~408,000] (pooled)6p21.33HLA-Crs3134792
18364390Psoriasis1.00E-08Illumina [~408,000] (pooled)20q13.13SPATA2rs495337
18347602Schizophrenia2E-06Affymetrix [492,900]15q25.3AGBL1rs16977195
18347602Schizophrenia7E-06Affymetrix [492,900]Xq28Intergenicrs2159767
18347602Schizophrenia4E-06Affymetrix [492,900]1p36.22Intergenicrs4846033
18347602Schizophrenia0.000005Affymetrix [492,900]13q12.2Intergenicrs9512730
18347602Schizophrenia0.000006Affymetrix [492,900]16p12.2ACSM1, BUCS1rs151222
18347602Schizophrenia2E-06Affymetrix [492,900]1q31.1Intergenicrs10911902
18326623Breast cancer3.00E-08Affymetrix [150,080]6q22.33ECHDC1,RNF146rs2180341
18332876Schizophrenia1.00E-06Illumina [~550,000] (pooled)12q24.23CCDC60rs11064768
18327256Serum urate3.00E-70Affymetrix [335,152]4p16.1SLC2A9rs7442295
18327257Serum urate3.00E-09Illumina [308,140]4p16.1SLC2A9rs737267
18325910ObesityNSAffymetrix [379,319]NRNR
18317468Bipolar disorderNSAffymetrix [372,193]NRNR
18311140Celiac disease3.00E-11Illumina [310,605]1q31.2RGS1rs2816316
18311140Celiac disease7.00E-08Illumina [310,605]6q25.3TAGAPrs1738074
18311140Celiac disease4.00E-09Illumina [310,605]2q12.1IL1RL1,IL18R1,IL18RAP, SLC9A4rs13015714
18311140Celiac disease5.00E-09Illumina [310,605]3q28LPPrs1464510
18311140Celiac disease1.00E-09Illumina [310,605]3q25.33IL12A, SCHIP1rs17810546
18311140Celiac disease3.00E-13Illumina [310,605]4q27KIAA1109, ADAD1, IL2, IL21rs6822844
18311140Celiac disease8.00E-08Illumina [310,605]12q24.12SH2B3, ATXN2rs653178
18311140Celiac disease3.00E-07Illumina [310,605]3p21.31CCR1, CCR3rs6441961
18316681Methamphetamine dependenceNSAffymetrix [up to 466,883] (pooled)NRNR
18313986Amyotrophic lateral sclerosisPendingIllumina [317,503]PendingPending
18282107Schizophrenia9.00E-07Affymetrix [510,552]7q22.1RELNrs7341475
18264097Prostate cancer9.00E-29Illumina [541,129]10q11.23MSMBrs10993994
18264097Prostate cancer6.00E-10Illumina [541,129]6q25.3SLC22A3rs9364554
18264097Prostate cancer2.00E-09Illumina [541,129]Xp11.22NUDT10, NUDT11rs5945619
18264097Prostate cancer1.00E-07Illumina [541,129]8q24.21Intergenicrs1016343
18264097Prostate cancer1.00E-06Illumina [541,129]17q24.3Intergenicrs1859962
18264097Prostate cancer9.00E-12Illumina [541,129]17q12HNF1Brs7501939
18264097Prostate cancer3.00E-16Illumina [541,129]8q24.21Intergenicrs4242384
18264097Prostate cancer9.00E-13Illumina [541,129]8q24.21Intergenicrs6983267
18264097Prostate cancer3.00E-08Illumina [541,129]3p12.1SLC22A3rs2660753
18264097Prostate cancer1.00E-09Illumina [541,129]7q21.3LMTK2rs6465657
18264097Prostate cancer2.00E-18Illumina [541,129]19q13.33KLK3rs2735839
18264097Prostate cancer2.00E-12Illumina [541,129]11q13.2Intergenicrs7931342
18264098Prostate cancer4.00E-13Illumina [310,520]Xp11.22NUDT10, NUDT11, LOC340602, GSPT2, MAGED1rs5945572
18264098Prostate cancer8.00E-09Illumina [310,520]2p15EHBP1rs721048
18264096Prostate cancer7.00E-13Illumina [527,869]10q11.23MSMBrs10993994
18264096Prostate cancer1.00E-09Illumina [527,869]17q12HNF1Brs4430796
18264096Prostate cancer3.00E-19Illumina [527,869]8q24.21Intergenicrs4242382
18264096Prostate cancer7.00E-12Illumina [527,869]8q24.21Intergenicrs6983267
18264096Prostate cancer2E-06Illumina [527,869]7p15.2JAZF1rs10486567
18264096Prostate cancer2.00E-09Illumina [527,869]11q13.2Intergenicrs10896449
18264096Prostate cancer2.00E-07Illumina [527,869]10q26.13CTBP2rs4962416
18262040LDL cholesterol1.00E-33Affymetrix and Illumina [up to 461,986]1p13.3CELSR2,PSRC1rs599839
18262040LDL cholesterol1.00E-20Affymetrix and Illumina [up to 461,986]19q13.32APOC1rs4420638
18262040LDL cholesterol1.00E-09Affymetrix and Illumina [up to 461,986]2p24.1APOBrs562338
18245381Fetal hemoglobin levels1.00E-21Affymetrix [362,129]11p15.4HBBrs4910742
18245381Fetal hemoglobin levels7.00E-35Affymetrix [362,129]2p15BCL11Ars1186868
18239089Recombination rate (females)2.00E-12Illumina [309,241]4p16.3RNF212,SPON2rs1670533
18239089Recombination rate (males)3.00E-24Illumina [309,241]4p16.3RNF212,SPON2rs3796619
18227835Nicotine dependenceNSAffymetrix [460,959]NRNR
18252221Iris color1.00E-43Affymetrix and Illumina [up to ~500,000] (pooled)15q13.1HERC2rs916977
18067574General cognitive abilityNSAffymetrix [449,127]NRNR
18204446Systemic lupus erythematosus in women2.00E-23Illumina [317,501]16p11.2ITGAMrs9888739
18204446Systemic lupus erythematosus in women1.00E-07Illumina [317,501]1q25.1Intergenicrs10798269
18204446Systemic lupus erythematosus in women3.00E-10Illumina [317,501]11p15.5KIAA1542rs4963128
18204446Systemic lupus erythematosus in women2.00E-52Illumina [317,501]6p21.33HLA regionrs3131379
18204446Systemic lupus erythematosus in women4.00E-19Illumina [317,501]7q32.1IRF5, TNPO3rs12537284
18204446Systemic lupus erythematosus in women7.00E-09Illumina [317,501]3p14.3PXKrs6445975
18204098Systemic lupus erythematosus1.00E-10Illumina [502,033]8p23.1C8orf13, BLKrs13277113
18204098Systemic lupus erythematosus9.00E-14Illumina [502,033]2q32.3STAT4rs7574865
18204098Systemic lupus erythematosus4E-06Illumina [502,033]5p12GHRrs979233
18204098Systemic lupus erythematosus0.000006Illumina [502,033]18q22.3SOCS6rs17083844
18204098Systemic lupus erythematosus7E-06Illumina [502,033]1p31.3NEGR1rs12141391
18204098Systemic lupus erythematosus2.00E-11Illumina [502,033]7q32.1IRF5, TNPO3rs10488631
18204098Systemic lupus erythematosus3.00E-21Illumina [502,033]6p21.32HLA-DQA1rs2187668
18204098Systemic lupus erythematosus0.000003Illumina [502,033]9q34.13NTNG2rs11243676
18204098Systemic lupus erythematosus3.00E-11Illumina [502,033]16p11.2ITGAM, ITGAXrs11574637
18204447Systemic lupus erythematosus4.00E-10Affymetrix [85,042]4q24BANK1rs10516487
18198356Type 1 diabetes9.00E-10Illumina [543,071]12q13.2RAB5B, SUOX, IKZF4, ERBB3, CDK2rs1701704
18195134Response to interferon beta therapyNSAffymetrix [~100,000] (pooled)NRNR
18193044HDL cholesterol2.00E-13Affymetrix [389,878]1q42.13GALNT2rs4846914
18193044HDL cholesterol3.00E-10Affymetrix [389,878]9q31.1ABCA1rs3890182
18193044HDL cholesterol2.00E-32Affymetrix [389,878]15q22.1LIPCrs1800588
18193044HDL cholesterol9.00E-23Affymetrix [389,878]8p21.3LPLrs328
18193044HDL cholesterol2.00E-07Affymetrix [389,878]18q21.1LIPG, ACAA2rs2156552
18193044HDL cholesterol1.00E-73Affymetrix [389,878]16q13CETPrs1800775
18193044LDL cholesterol3.00E-29Affymetrix [389,878]1p13.3CELSR2,PSRC1,SORT1rs646776
18193044LDL cholesterol3.00E-08Affymetrix [389,878]19p13.11CILP2, PBX4rs16996148
18193044LDL cholesterol1.00E-60Affymetrix [389,878]19q13.32APOE, APOC1, APOC4, APOC2rs4420638
18193044LDL cholesterol2.00E-51Affymetrix [389,878]19p13.2LDLRrs6511720
18193044LDL cholesterol2.00E-44Affymetrix [389,878]1p32.3PCSK9rs11591147
18193044LDL cholesterol1.00E-20Affymetrix [389,878]5q13.3HMGCRrs12654264
18193044LDL cholesterol1.00E-21Affymetrix [389,878]2p24.1APOBrs693
18193044Triglycerides7.00E-22Affymetrix [389,878]7q11.23BCL7B, TBL2, MLXIPLrs17145738
18193044Triglycerides7.00E-15Affymetrix [389,878]1q42.13GALNT2rs4846914
18193044Triglycerides4.00E-09Affymetrix [389,878]19p13.11CILP2, PBX4rs16996148
18193044Triglycerides2.00E-08Affymetrix [389,878]1p31.3ANGPTL3, DOCK7, ATG4Crs12130333
18193044Triglycerides2.00E-28Affymetrix [389,878]8p21.3LPLrs328
18193044Triglycerides3.00E-14Affymetrix [389,878]2p23.3GCKRrs780094
18193044Triglycerides2.00E-07Affymetrix [389,878]2p24.1APOBrs693
18193044Triglycerides2.00E-17Affymetrix [389,878]11q23.3APOA1, APOC3, APOA4, APOA5, ZNF259, BUD13rs28927680
18193044Triglycerides4.00E-17Affymetrix [389,878]8q24.13TRIB1rs17321515
18193046Triglycerides1.00E-10Perlegen [up to 216,774]7q11.23MLXIPLrs3812316
18193046Triglycerides5.00E-08Perlegen [up to 216,774]11q23.3APOA1,KIAA0999,LOC645044rs2075292
18193046Triglycerides5.00E-12Perlegen [up to 216,774]8p21.3LPL, C8orf35, SLC18A1rs326
18193046Triglycerides2.00E-26Perlegen [up to 216,774]11q23.3LOC440069, MGC13125rs1558861
18193045Height2.00E-16Illumina and Affymetrix [~2,261,000] (imputed)20q11.22BFZBrs6060369
18193045Height0.000003Illumina and Affymetrix [~2,261,000] (imputed)5q14.1HOMER1rs10078095
18193045Height1.00E-06Illumina and Affymetrix [~2,261,000] (imputed)3q23ZBTB38rs724016
18193045Height4.00E-07Illumina and Affymetrix [~2,261,000] (imputed)4q12PDGFRArs17690232
18193045Height8.00E-07Illumina and Affymetrix [~2,261,000] (imputed)15q26.1POLGrs4932217
18193043HDL cholesterol3.00E-08Illumina and Affymetrix [~2,261,000] (imputed)12q24.11MVK,MMABrs2338104
18193043HDL cholesterol1.00E-07Illumina and Affymetrix [~2,261,000] (imputed)16q22.1LCATrs255052
18193043HDL cholesterol1.00E-10Illumina and Affymetrix [~2,261,000] (imputed)9q31.1ABCA1rs4149268
18193043HDL cholesterol3.00E-14Illumina and Affymetrix [~2,261,000] (imputed)1q42.13GALNT2rs2144300
18193043HDL cholesterol4.00E-19Illumina and Affymetrix [~2,261,000] (imputed)8p21.3LPLrs10503669
18193043HDL cholesterol3.00E-20Illumina and Affymetrix [~2,261,000] (imputed)15q22.1LIPCrs4775041
18193043HDL cholesterol3.00E-31Illumina and Affymetrix [~2,261,000] (imputed)16q13CETPrs9989419
18193043HDL cholesterol7.00E-39Illumina and Affymetrix [~2,261,000] (imputed)16q13CETPrs1864163
18193043HDL cholesterol2.00E-57Illumina and Affymetrix [~2,261,000] (imputed)16q13CETPrs3764261
18193043HDL cholesterol6.00E-12Illumina and Affymetrix [~2,261,000] (imputed)18q21.1LIPGrs2156552
18193043LDL cholesterol6.00E-33Illumina and Affymetrix [~2,261,000] (imputed)1p13.3CELSR2,PSRC1,SORT1rs599839
18193043LDL cholesterol5.00E-08Illumina and Affymetrix [~2,261,000] (imputed)6p21.32B3GALT4rs2254287
18193043LDL cholesterol3.00E-43Illumina and Affymetrix [~2,261,000] (imputed)19q13.32APOE,APOC1,APOC4rs4420638
18193043LDL cholesterol4.00E-11Illumina and Affymetrix [~2,261,000] (imputed)1p32.3PCSK9rs11206510
18193043LDL cholesterol4.00E-26Illumina and Affymetrix [~2,261,000] (imputed)19p13.2LDLRrs6511720
18193043LDL cholesterol6.00E-22Illumina and Affymetrix [~2,261,000] (imputed)2p24.1APOBrs562338
18193043LDL cholesterol3.00E-09Illumina and Affymetrix [~2,261,000] (imputed)19p13.11NCAN,CILP2rs16996148
18193043Triglycerides6.00E-32Illumina and Affymetrix [~2,261,000]] (imputed)2p23.3GCKRrs780094
18193043Triglycerides8.00E-07Illumina and Affymetrix [~2,261,000]] (imputed)1q42.13GALNT2rs2144300
18193043Triglycerides3.00E-09Illumina and Affymetrix [~2,261,000]] (imputed)19p13.3NCAN,CILP2rs16996148
18193043Triglycerides2.00E-10Illumina and Affymetrix [~2,261,000]] (imputed)1p31.3ANGPTL3rs1748195
18193043Triglycerides2.00E-08Illumina and Affymetrix [~2,261,000]] (imputed)15q22.1LIPCrs4775041
18193043Triglycerides4.00E-22Illumina and Affymetrix [~2,261,000]] (imputed)8p21.3LPLrs10503669
18193043Triglycerides1.00E-26Illumina and Affymetrix [~2,261,000]] (imputed)11q23.3APOA5, APOA4, APOC3, APOA1rs12286037
18193043Triglycerides7.00E-13Illumina and Affymetrix [~2,261,000]] (imputed)8q24.13TRIB1rs17321515
18193043Triglycerides2.00E-12Illumina and Affymetrix [~2,261,000]] (imputed)7q11.23MLXIPLrs17145738
18179892LDL cholesterol1.00E-07Affymetrix [400,496]1p13.3CELSR2,PSRC1rs599839
18179892LDL cholesterol5.00E-07Affymetrix [400,496]2p23.3GCKRrs780094
18179892LDL cholesterol3.00E-11Affymetrix [400,496]11q23.3APOA1,APOC3,APOA5rs6589566
18179892Serum urate2.00E-15Affymetrix [400,496]4p16.1SLC2A9,WDR1rs7442295
18159244Early onset extreme obesity1.00E-07Affymetrix [440,794]16q12.2FTOrs1121980
18073375Prostate cancerNSIllumina & Affymetrix [60,275]NRNR
18084291Amyotrophic lateral sclerosis5.00E-08Illumina [311,946]7q36.2DPP6rs10260404
18084291Amyotrophic lateral sclerosis0.000009Illumina [311,946]15q22.1LIPCrs3825776
18084291Amyotrophic lateral sclerosis0.000009Illumina [311,946]2p24.2Intergenicrs7580332
18057069Amyotrophic lateral sclerosis0.000003Illumina [497,917]7q36.2DPP6rs10260404
18075462Coronary spasm in women9.00E-07Affymetrix [97,552]14q21.1Intergenicrs10498345
17998437Alzheimer's disease2.00E-44Affymetrix [469,438]19q13.32APOE, APOCrs4420638
17997608Serum urate2.00E-16Affymetrix [362,129]4p16.1GLUT9rs6855911
17982456Rheumatoid arthritis1.00E-09Affymetrix [79,853]6q23.3TNFAIP3, OLIG3rs10499194
17982456Rheumatoid arthritis1.00E-07Affymetrix [79,853]6q23.3TNFAIP3, OLIG3rs6920220
17975299Alzheimer's disease1.00E-39Affymetrix [~502,627]19q13.32APOErs4420638
17952075Blond vs. brown hair4.00E-30Illumina [317,511]12q21.33KITLGrs12821256
17952075Blond vs. brown hair2.00E-13Illumina [317,511]16q24.3MC1Rrs1805007
17952075Blond vs. brown hair6.00E-35Illumina [317,511]15q13.1OCA2rs1667394
17952075Blond vs. brown hair1.00E-48Illumina [317,511]14q32.12SLC24A4rs12896399
17952075Blue vs brown eyes0Illumina [317,511]15q13.1OCA2rs1667394
17952075Blue vs. green eyes4.00E-38Illumina [317,511]14q32.12SLC24A4rs12896399
17952075Blue vs. green eyes2.00E-53Illumina [317,511]15q13.1OCA2rs1667394
17952075Blue vs. green eyes3.00E-12Illumina [317,511]11q14.3TYRrs1393350
17952075Freckles4.00E-18Illumina [317,511]6p25.3SEC5L1,IRF4rs1540771
17952075Freckles2.00E-11Illumina [317,511]11q14.3TYRrs1042602
17952075Freckles1.00E-96Illumina [317,511]16q24.3MC1Rrs1805007
17952075Red vs non-red hair0Illumina [317,511]16q24.3MC1Rrs1805007
17952075Skin sensitivity to sun2E-06Illumina [317,511]11q14.3TYRrs1393350
17952075Skin sensitivity to sun2.00E-55Illumina [317,511]16q24.3MC1Rrs1805007
17999355Skin pigmentation by reflectance spectroscopy1.00E-50Perlegen [1,502,205] (pooled)15q21.1SLC24A5rs1834640
17999355Skin pigmentation by reflectance spectroscopy4.00E-10Perlegen [1,502,205] (pooled)11q14.3TYRrs1042602
17999355Skin pigmentation by reflectance spectroscopy3.00E-11Perlegen [1,502,205] (pooled)5p13.3SLC45A2rs16891982
17934461Colorectal cancer1.00E-12Illumina [547,647]18q21.1SMAD7rs4939827
17911428LupusNSAffymetrix [241,701]NRNR
17903293Select biomarker traits1.00E-14Affymetrix [70,897]1q23.2FCER1A,OR10J3rs2494250
17903293Select biomarker traits3.00E-08Affymetrix [70,897]1q23.2CRPrs2794520
17903293Select biomarker traits5.00E-07Affymetrix [70,897]1p31.1Intergenicrs7552393
17903293Select biomarker traits2E-06Affymetrix [70,897]10q21.1Intergenicrs583012
17903293Select biomarker traits2E-06Affymetrix [70,897]6q21Intergenicrs1417352
17903293Select biomarker traits1.00E-06Affymetrix [70,897]6q15Intergenicrs10485165
17903293Select biomarker traits1.00E-06Affymetrix [70,897]5q23.2Intergenicrs1119582
17903293Select biomarker traits1.00E-06Affymetrix [70,897]10q26.2PTPRE, MKI67rs2387326
17903293Select biomarker traits1.00E-06Affymetrix [70,897]15q21.3Intergenicrs10518765
17903293Select biomarker traits1.00E-06Affymetrix [70,897]1q23.2IGSF4Brs10489849
17903293Select biomarker traits1.00E-06Affymetrix [70,897]9q21.32Intergenicrs1998303
17903293Select biomarker traits1.00E-06Affymetrix [70,897]4q31.1CLGN, ELMOD2rs17532515
17903293Select biomarker traits4E-06Affymetrix [70,897]14q23.2Intergenicrs8005745
17903293Select biomarker traits0.000003Affymetrix [70,897]7p21.3Intergenicrs7778619
17903293Select biomarker traits0.000003Affymetrix [70,897]1q23.2IGSF4Brs1474747
17903293Select biomarker traits0.000003Affymetrix [70,897]11q23.2DRD2rs1079596
17903293Select biomarker traits0.000003Affymetrix [70,897]13q21.1Intergenicrs10507577
17903293Select biomarker traits2E-06Affymetrix [70,897]13q14.11Intergenicrs10492681
17903293Select biomarker traits2E-06Affymetrix [70,897]7p13Intergenicrs1486139
17903293Select biomarker traits8.00E-07Affymetrix [70,897]19q12ZNF536rs746961
17903293Select biomarker traits4.00E-12Affymetrix [70,897]1q23.2OR10J1rs4128725
17903300Body mass index1.00E-07Affymetrix [70,897]7q32.3Intergenicrs1106683
17903300Body mass index2E-06Affymetrix [70,897]7q23.3Intergenicrs1106684
17903300Body mass index8E-06Affymetrix [70,897]13q21.32Intergenicrs1333026
17903300Waist circumference traits2.00E-07Affymetrix [70,897]8q21.1GDAP1rs4471028
17903300Waist circumference traits2E-06Affymetrix [70,897]3q13.31Intergenicrs1875517
17903308Sleep duration1.00E-07Affymetrix [70,897]3p22.1MYR1Prs6599077
17903308Sleep duration4E-06Affymetrix [70,897]13q21.2Intergenicrs10492604
17903308Sleepiness3.00E-08Affymetrix [70,897]5q11.2PDE4Drs1823068
17903308Sleepiness0.000003Affymetrix [70,897]8q13.3EYA1rs2218488
17903292Cystatin C9.00E-09Affymetrix [70,897]20p11.21CST9L, CST9, CST3rs1158167
17903292Thyroid stimulating hormone4E-06Affymetrix [70,897]7p15.3Intergenicrs6977660
17903292Thyroid stimulating hormone8E-06Affymetrix [70,897]7p15.3RAPGEF5rs10499559
17903292Thyroid stimulating hormone7E-06Affymetrix [70,897]6q21HACE1rs9322817
17903292Urinary albumin excretion2E-06Affymetrix [70,897]11q23.2FAM55Brs1712790
17903292Urinary albumin excretion8E-06Affymetrix [70,897]21q21.3Intergenicrs9305354
17903299Blood lipid traitsNSAffymetrix [70,897]NRNR
17903296Bone mineral density2.00E-07Affymetrix [70,897]13q21.31Intergenicrs9317284
17903296Bone mineral density1.00E-06Affymetrix [70,897]10p15.2Intergenicrs2165468
17903296Bone mineral density1.00E-06Affymetrix [70,897]20q11.23CTNNBL1rs4811196
17903296Bone mineral density0.000003Affymetrix [70,897]3p24.1RBMS3rs10510628
17903296Bone mineral density3.00E-07Affymetrix [70,897]16q23.3Intergenicrs4087296
17903296Bone mineral density1.00E-06Affymetrix [70,897]12q21.1Intergenicrs10506701
17903296Bone mineral density0.000003Affymetrix [70,897]7q35CNTNAP2rs2214681
17903296Bone mineral density2E-06Affymetrix [70,897]4p16.1Intergenicrs9291683
17903296Hip geometry2.00E-07Affymetrix [70,897]5q14.3GPR98rs10514345
17903296Hip geometry2.00E-07Affymetrix [70,897]5p14.1Intergenicrs2548003
17903296Hip geometry2.00E-07Affymetrix [70,897]12q21.31Intergenicrs10506821
17903296Hip geometry0.000003Affymetrix [70,897]6p24.1PHACTR1rs4715166
17903296Hip geometry6.00E-07Affymetrix [70,897]1p11.2Intergenicrs6600671
17903296Hip geometry4E-06Affymetrix [70,897]11q23.2Intergenicrs638882
17903296Hip geometry2E-06Affymetrix [70,897]18q12.1Intergenicrs4131805
17903296Hip geometry0.000003Affymetrix [70,897]12p13.31VAMP1rs10492096
17903296Hip geometry7.00E-07Affymetrix [70,897]11q14.1Intergenicrs1452928
17903296Hip geometry2E-06Affymetrix [70,897]3p14.1Intergenicrs922948
17903296Hip geometry5.00E-07Affymetrix [70,897]3q12.3Intergenicrs991258
17903296Hip geometry0.000003Affymetrix [70,897]13q13.3Intergenicrs1590305
17903296Hip geometry6.00E-07Affymetrix [70,897]5q13.2ZNF366rs10515148
17903296Hip geometry4E-06Affymetrix [70,897]3p24.3KCNH8rs2053506
17903296Hip geometry6.00E-07Affymetrix [70,897]3p14.3ERC2rs2054989
17903296Hip geometry2.00E-07Affymetrix [70,897]8p12NRG1rs10503887
17903304Atrial fibrillation0.000005Affymetrix [70,897]13q14Intergenicrs958546
17903304Atrial fibrillation0.000009Affymetrix [70,897]11q22.1CNTN5rs10501920
17903304Atrial fibrillation8E-06Affymetrix [70,897]15q23KIAA1598rs4776472
17903304Heart failure0.000009Affymetrix [70,897]10q25.3KIAA1598rs740363
17903304Major CVD7E-06Affymetrix [70,897]6p24.1Intergenicrs499818
17903302Blood pressure2E-06Affymetrix [70,897]1p31.3Intergenicrs10493340
17903302Blood pressure0.000003Affymetrix [70,897]8q13.3Intergenicrs1963982
17903302Blood pressure4E-06Affymetrix [70,897]5q22.1CAMK4rs10491334
17903302Blood pressure7E-06Affymetrix [70,897]6q15Intergenicrs2509458
17903302Blood pressure1.00E-09Affymetrix [70,897]16q23.3CDH13rs3096277
17903302Blood pressure3.00E-07Affymetrix [70,897]2q36.3CCL20, WDR69rs7591163
17903302Blood pressure0.000005Affymetrix [70,897]14q24.3C14orf118rs2121070
17903302Blood pressure4E-06Affymetrix [70,897]3p26.3CNTN4rs4370013
17903302Blood pressure0.000003Affymetrix [70,897]14q24.3Intergenicrs935334
17903302Tonometry2E-06Affymetrix [70,897]20q13.13PREX1rs6063312
17903302Tonometry2E-06Affymetrix [70,897]13q13.3GPC6rs6492654
17903302Tonometry4E-06Affymetrix [70,897]17p12HS3ST3A1rs10521232
17903302Tonometry8E-06Affymetrix [70,897]7q33EXOC4rs10488172
17903302Tonometry4E-06Affymetrix [70,897]3q24SLC9A9rs1371924
17903302Tonometry4E-06Affymetrix [70,897]1q25.1TNRrs3766680
17903302Tonometry0.000003Affymetrix [70,897]2q14.3CNTNAP5rs1367248
17903302Tonometry2E-06Affymetrix [70,897]8p22VPS37Ars3793427
17903302Tonometry0.000006Affymetrix [70,897]3p22.3Intergenicrs10514688
17903302Tonometry0.000006Affymetrix [70,897]9q31.2Intergenicrs7042864
17903302Tonometry2.00E-07Affymetrix [70,897]3p24.1TGFBR2rs3773643
17903302Tonometry8E-06Affymetrix [70,897]6q25.2SYNE1rs1322512
17903302Tonometry0.000003Affymetrix [70,897]5q14.3MEF2Crs770189
17903295Aging traits1.00E-08Affymetrix [70,897]2p12Intergenicrs10496265
17903295Aging traits8E-06Affymetrix [70,897]3q25.31KCNAB1rs3772255
17903295Aging traits7E-06Affymetrix [70,897]15q25.3KLHL25rs7176093
17903295Aging traits6.00E-07Affymetrix [70,897]12q24.23CCDC60rs7137869
17903295Aging traits0.000006Affymetrix [70,897]1q42.3GNG4rs291353
17903295Aging traits2E-06Affymetrix [70,897]2q24.1GALNT13rs958672
17903295Aging traits3.00E-07Affymetrix [70,897]2p12Intergenicrs10496262
17903295Aging traits0.000003Affymetrix [70,897]7q21.11Intergenicrs2371208
17903295Aging traits7.00E-08Affymetrix [70,897]12p11.22Intergenicrs1463605
17903295Aging traits8.00E-08Affymetrix [70,897]11q14.3Intergenicrs1528753
17903295Morbidity-free survival2.00E-09Affymetrix [70,897]1q24.2DPTrs1412337
17903295Morbidity-free survival2.00E-09Affymetrix [70,897]5p15.32Intergenicrs32566
17903295Morbidity-free survival8.00E-08Affymetrix [70,897]6p24.3Intergenicrs10484246
17903295Morbidity-free survival9.00E-07Affymetrix [70,897]16q21Intergenicrs2639889
17903295Morbidity-free survival5.00E-07Affymetrix [70,897]8p22Intergenicrs4831837
17903298Diabetes related insulin traits2E-06Affymetrix [70,897]14q12Intergenicrs2877832
17903298Diabetes related insulin traits0.000009Affymetrix [70,897]13q21.33Intergenicrs2066219
17903298Diabetes related insulin traits0.000003Affymetrix [70,897]14q12Intergenicrs2877832
17903298Diabetes related insulin traits8E-06Affymetrix [70,897]7p15.1CPVLrs10486607
17903298Fasting plasma glucose2.00E-08Affymetrix [70,897]8p11.21ZMAT4rs2722425
17903298Fasting plasma glucose0.000005Affymetrix [70,897]4q27PRDM5rs180730
17903298Fasting plasma glucose0.000006Affymetrix [70,897]4q27PRDM5rs180730
17903298Fasting plasma glucose0.000009Affymetrix [70,897]8p11.21ZMAT4rs2722425
17903298Fasting plasma glucose7E-06Affymetrix [70,897]5q23.3Intergenicrs7731657
17903298Fasting plasma glucose0.000005Affymetrix [70,897]3p24.1Intergenicrs10510634
17903298Incident diabetes7.00E-07Affymetrix [70,897]2q32.3TMEFF2rs10497721
17903305Breast cancer7.00E-07Affymetrix [70,897]12q21.1Intergenicrs1154865
17903305Breast cancer0.000006Affymetrix [70,897]15q21.1FBN1rs1876206
17903305Breast cancer0.000006Affymetrix [70,897]21q21.3GRIK1rs458685
17903305Breast cancer0.000005Affymetrix [70,897]2p16.1Intergenicrs10490113
17903305Breast cancer0.000003Affymetrix [70,897]7q11.22Intergenicrs10263639
17903305Breast cancer5.00E-07Affymetrix [70,897]5q34Intergenicrs6556756
17903305Breast cancer8.00E-08Affymetrix [70,897]17q21.33COL1A1rs2075555
17903305Breast cancer1.00E-06Affymetrix [70,897]18q21.2Intergenicrs1978503
17903305Breast cancer2E-06Affymetrix [70,897]13q32.1ABCC4rs1926657
17903305Prostate cancer2E-06Affymetrix [70,897]3p22.2CTDSPLrs9311171
17903305Prostate cancer2E-06Affymetrix [70,897]13q33.1Intergenicrs1529276
17903305Prostate cancer0.000003Affymetrix [70,897]6p12.2PKHD1rs10498792
17903305Prostate cancer0.000003Affymetrix [70,897]5q14.3HAPLN1rs4466137
17903305Prostate cancer0.000005Affymetrix [70,897]3q24Intergenicrs345013
17903306Electrocardiographic traits8E-06Affymetrix [70,897]13q12.2RPL21rs10507380
17903306Electrocardiographic traits3.00E-07Affymetrix [70,897]2q22.1Intergenicrs882300
17903306Heart rate variability traits7E-06Affymetrix [70,897]4q34NEIL3rs1395479
17903306Heart rate variability traits8E-06Affymetrix [70,897]13q13.3DCAMKL1rs9315385
17903303Coronary artery calcification1.00E-06Affymetrix [70,897]1p22.2Intergenicrs2390582
17903303Coronary artery calcification7E-06Affymetrix [70,897]12q23.2DR1Mrs10507130
17903303Coronary artery calcification0.000006Affymetrix [70,897]14q24.2NUMBrs10483853
17903303Other subclinical atherosclerosis traits4.00E-07Affymetrix [70,897]2q33.2ABI2rs1376877
17903303Other subclinical atherosclerosis traits2E-06Affymetrix [70,897]10q11.22LRRC18rs3849150
17903303Other subclinical atherosclerosis traits0.000005Affymetrix [70,897]5p15.2DNAH5rs2896103
17903303Other subclinical atherosclerosis traits0.000009Affymetrix [70,897]5p15.2DNAH5rs1502050
17903303Other subclinical atherosclerosis traits0.000009Affymetrix [70,897]11q14.3Intergenicrs1350445
17903303Other subclinical atherosclerosis traits7E-06Affymetrix [70,897]4q28.1Intergenicrs1320267
17903303Other subclinical atherosclerosis traits0.000006Affymetrix [70,897]5p15.2DNAH5rs7715811
17903303Other subclinical atherosclerosis traits0.000006Affymetrix [70,897]1q31.1Intergenicrs1400544
17903297Cognitive test performance1.00E-06Affymetrix [70,897]1p22.2Intergenicrs2179965
17903297Cognitive test performance2E-06Affymetrix [70,897]4q13.2Intergenicrs1155865
17903297Cognitive test performance2E-06Affymetrix [70,897]6p23Intergenicrs6914079
17903297Cognitive test performance2E-06Affymetrix [70,897]21q21.3Intergenicrs2832077
17903297Cognitive test performance2E-06Affymetrix [70,897]14q24.3Intergenicrs2352904
17903297Cognitive test performance0.000003Affymetrix [70,897]5q32Intergenicrs9325032
17903297Cognitive test performance4E-06Affymetrix [70,897]11q14.1Intergenicrs530965
17903297Cognitive test performance0.000006Affymetrix [70,897]11q25NCAPD3rs1031381
17903297Cognitive test performance0.000009Affymetrix [70,897]2q22.1Intergenicrs934299
17903297Cognitive test performance8E-06Affymetrix [70,897]9q22.2DIRAS2rs1831521
17903297Cognitive test performance8E-06Affymetrix [70,897]12p11.1Intergenicrs9300212
17903297Cognitive test performance0.000006Affymetrix [70,897]1q42.2TARBP1rs10489896
17903297Cognitive test performance0.000005Affymetrix [70,897]17q22PPM1Ers9303401
17903297Cognitive test performance0.000003Affymetrix [70,897]12q23.3POLR3B, RFX4rs3891355
17903297Volumetric brain MRI4.00E-08Affymetrix [70,897]20q13.33CDH4rs1970546
17903297Volumetric brain MRI0.000003Affymetrix [70,897]11p13EHFrs5028798
17903297Volumetric brain MRI0.000006Affymetrix [70,897]11q22.1CNTN5rs952700
17903297Volumetric brain MRI0.000009Affymetrix [70,897]4q31.3Intergenicrs360929
17903297Volumetric brain MRI0.000003Affymetrix [70,897]11q23.2NNMTrs2847476
17903301Echocardiographic traits1.00E-07Affymetrix [70,897]4p15.31SLIT2rs1379659
17903301Echocardiographic traits7E-06Affymetrix [70,897]5q14.3Intergenicrs4920799
17903301Echocardiographic traits7E-06Affymetrix [70,897]1p31.3PDE4Brs10493389
17903301Echocardiographic traits0.000005Affymetrix [70,897]4p15.31SLIT2rs666088
17903301Echocardiographic traits0.000005Affymetrix [70,897]8q13.3KCNB2rs10504543
17903301Echocardiographic traits0.000006Affymetrix [70,897]2q36.1Intergenicrs10498091
17903301Echocardiographic traits0.000006Affymetrix [70,897]1q31.1FAM5Crs1935881
17903301Echocardiographic traits2E-06Affymetrix [70,897]6q15SPACA1rs366676
17903301Endothelial function traits9.00E-07Affymetrix [70,897]10q24.33OBFC1rs3814219
17903301Exercise treadmill test traits0.000003Affymetrix [70,897]4q25NOLA1rs6847149
17903301Exercise treadmill test traits0.000005Affymetrix [70,897]11q22.3Intergenicrs746463
17903301Exercise treadmill test traits0.000006Affymetrix [70,897]8p12WRNrs2553268
17903301Exercise treadmill test traits4E-06Affymetrix [70,897]1q43RYR2rs2819770
17903307Mean forced vital capacity from 2 exams2E-06Affymetrix [70,897]7q21.3COL1A2rs441051
17903307Mean forced vital capacity from 2 exams4E-06Affymetrix [70,897]4q25Intergenicrs10516541
17903307Other pulmonary function traits1.00E-06Affymetrix [70,897]15q11.2SNRPNrs3867498
17903307Other pulmonary function traits7E-06Affymetrix [70,897]14q23.1Intergenicrs808225
17903307Other pulmonary function traits8E-06Affymetrix [70,897]17p12CDRT4rs2906966
17903307Other pulmonary function traits0.000009Affymetrix [70,897]7q34Intergenicrs357394
17903307Other pulmonary function traits7E-06Affymetrix [70,897]1q21.3IL6Rrs4129267
17903307Other pulmonary function traits0.000006Affymetrix [70,897]14q22.1NID2rs730532
17903307Other pulmonary function traits0.000003Affymetrix [70,897]21q22.3ADARB1rs2838815
17903307Other pulmonary function traits0.000005Affymetrix [70,897]8q11.22SNTG1rs310558
17903307Other pulmonary function traits0.000005Affymetrix [70,897]2q36.3RHBDD1rs3820928
17903307Other pulmonary function traits4E-06Affymetrix [70,897]15q26.1FLJ32831rs1455782
17903294Factor VII7E-06Affymetrix [70,897]7p22.2Intergenicrs10488360
17903294Factor VII5.00E-16Affymetrix [70,897]13q34MCF2L, AB116074, AK092739, AK123267, AB0023600, F7, CR603372, F10, PROZrs561241
17903294Factor VII0.000009Affymetrix [70,897]3p26.1Intergenicrs4591494
17903294Factor VII8E-06Affymetrix [70,897]1p36.32Intergenicrs966321
17903294Hemostatic factors and hematological phenotypes2E-06Affymetrix [70,897]1p31.1NEGR1rs10493485
17903294Hemostatic factors and hematological phenotypes0.000003Affymetrix [70,897]5q21.3Intergenicrs4460176
17903294Hemostatic factors and hematological phenotypes1.00E-06Affymetrix [70,897]2p16.2Intergenicrs1160297
17903294Hemostatic factors and hematological phenotypes2.00E-07Affymetrix [70,897]1q23.2OR10J1,OR10J5rs4133289
17903294Hemostatic factors and hematological phenotypes0.000006Affymetrix [70,897]2p16.2Intergenicrs2357013
17903294Hemostatic factors and hematological phenotypes2.00E-07Affymetrix [70,897]14q21.3MAMDC1rs7159841
17903294Hemostatic factors and hematological phenotypes0.000006Affymetrix [70,897]20p12.3Intergenicrs6108011
17903294Hemostatic factors and hematological phenotypes8E-06Affymetrix [70,897]6q25.1MAP3K7IP2rs727979
17903294Hemostatic factors and hematological phenotypes0.000006Affymetrix [70,897]6q25.1Intergenicrs636864
17903294Hemostatic factors and hematological phenotypes0.000005Affymetrix [70,897]4p15.33Intergenicrs10489087
17903294Hemostatic factors and hematological phenotypes4E-06Affymetrix [70,897]1p34.3FLJ11730, BC016328rs9253
17903294Hemostatic factors and hematological phenotypes0.000005Affymetrix [70,897]12q14.2Intergenicrs10506458
17903294Hemostatic factors and hematological phenotypes4E-06Affymetrix [70,897]11q24.1Intergenicrs565229
17903294Hemostatic factors and hematological phenotypes0.000006Affymetrix [70,897]14q32.2Intergenicrs10484128
17903294Hemostatic factors and hematological phenotypes7.00E-08Affymetrix [70,897]11q11OR5AP2, OR5AR1, OR9G1, OR9G4rs1397048
17903294Hemostatic factors and hematological phenotypes0.000006Affymetrix [70,897]10p11.21ANKRD30Ars1200821
17903294Hemostatic factors and hematological phenotypes0.000006Affymetrix [70,897]5q21.1Intergenicrs1829883
17903294Hemostatic factors and hematological phenotypes2E-06Affymetrix [70,897]8q24.13Intergenicrs7844723
17848626Type 2 diabetes and 6 quantitative traitsNSAffymetrix [66,543]NRNR
17846125Type 2 diabetesNSAffymetrix [80,044]NRNR
17846124Type 2 diabetesNSAffymetrix [88,142]NRNR
17846126Type 2 diabetesNSAffymetrix [82,485]NRNR
17827064Amyotrophic lateral sclerosis0.000003Illumina [311,946]12p11ITPR2rs2306677
17804836Rheumatoid arthritis4.00E-14Illumina [297,086]9q34TRAF1-C5rs3761847
17804836Rheumatoid arthritis2.00E-11Illumina [297,086]1p13.2PTPN22rs2476601
17804836Rheumatoid arthritis1.00E-108Illumina [297,086]6p21.32HLA-DRB1rs660895
17804789Crohn's disease1.00E-08Perlegen [164,279]1p31.3IL23Rrs11209003,rs11209002,rs2064689,rs1004819,rs2902440,rs11465802,rs2201841,rs11465804,rs11209026,rs1343151,rs10889676,rs10889677,rs9988642,rs12567232,rs6669582,rs10789230
17804789Crohn's disease6.00E-17Perlegen [164,279]16q12.1NOD2rs5743289
17804789Crohn's disease2.00E-07Perlegen [164,279]1p31.3IL23Rrs11209002,rs2064689,rs1004819,rs2902440,rs11465802,rs2201841,rs11465804,rs11209026,rs1343151,rs10889676,rs10889677,rs9988642,rs12567232,rs6669582,rs10789230,rs11209003
17767159F-cell distribution6.00E-31Illumina [308,015]2p15.1BCL11Ars1427407
17767159F-cell distribution3.00E-36Illumina [308,015]6q23.3Intergenicrs9399137
17767159F-cell distribution2.00E-38Illumina [308,015]11p15.5HBBNR
17767157Height6.00E-16Affymetrix [364,301]12q14.3HMGA2rs1042725
17690259Exfoliation glaucoma3.00E-21Illumina [304,250]15q24.1LOXL1rs3825942
17684544Inflammatory bowel syndrome1.00E-21Affymetrix [92,387]16q12.1CARD15rs2076756
17684544Inflammatory bowel syndrome0.000003Affymetrix [92,387]11p15.1NELL1rs1793004
17684544Inflammatory bowel syndrome4.00E-07Affymetrix [92,387]5p13.1PTGER4rs1992660
17671248Amyotrophic lateral sclerosisNSAffymetrix and Illumina [776,955]NRNR
17653210Diabetic nephropathy8E-06NR [~80,000]7p14.2ELMO1rs741301
17667963Neuroticism2E-06Affymetrix [452,574] (pooled)5q11.2PDE4Drs702543
17660530Multiple sclerosis3.00E-08Affymetrix [334,923]10p15.1IL2RArs12722489
17660530Multiple sclerosis3.00E-07Affymetrix [334,923]5p13.2IL7RArs6897932
17660530Multiple sclerosis9.00E-81Affymetrix [334,923]6p21.32HLA-DRArs3135388
17660530Multiple sclerosis4E-06Affymetrix [334,923]16p13KIAA0350rs6498169
17660530Multiple sclerosis8E-06Affymetrix [334,923]1p22RPL5rs6604026
17660530Multiple sclerosis8E-06Affymetrix [334,923]9q33DBC1rs10984447
17611496Asthma9.00E-11Illumina [307,328]17q21Intergenicrs7216389
17658951Obesity-related traits9.00E-07Affymetrix [362,129]16q12.2FTOrs9930506
17658951Obesity-related traits3.00E-08Affymetrix [362,129]16q12.2FTOrs9930506
17658951Obesity-related traits9.00E-07Affymetrix [362,129]16q12.2FTOrs9930506
17641165HIV1 viral setpointNSIllumina [535,101]NRNR
17634447Restless legs syndrome1.00E-17Illumina [306,937]6p21.2BTBD9rs3923809
17634449Coronary disease3.00E-08Affymetrix [377,857]6q25.1MTHFD1Lrs6922269
17634449Coronary disease2.00E-07Affymetrix [377,857]2q36.3pseudogeners2943634
17634449Coronary disease1.00E-06Affymetrix [377,857]1q41MIA3rs17465637
17634449Coronary disease2.00E-07Affymetrix [377,857]15q22.33SMAD3rs17228212
17634449Coronary disease9.00E-08Affymetrix [377,857]10q11.21CXCL12rs501120
17634449Coronary disease4.00E-09Affymetrix [377,857]1p13.3PSRC1rs599839
17634449Coronary disease3.00E-19Affymetrix [377,857]9p21.3Intergenicrs1333049
17637780Restless legs syndrome3.00E-28Affymetrix [236,758]2p14MEIS1rs2300478
17637780Restless legs syndrome4.00E-18Affymetrix [236,758]6p21.2BTBD9rs9296249
17637780Restless legs syndrome1.00E-15Affymetrix [236,758]15q23MAP2K5, LBXCOR1rs12593813
17632509Gallstones1.00E-14Affymetrix [382,492]2p21ABCG8rs11887534
17632545Type 1 diabetes7.00E-11Illumina [543,071]16p13.13KIAA0350rs2903692
17632545Type 1 diabetes1.00E-07Illumina [543,071]1p13.2PTPN22rs2476601
17632545Type 1 diabetes4.00E-09Illumina [543,071]11p15.5INSrs1004446
17632545Type 1 diabetes1.00E-16Illumina [543,071]6p21.32HLA-Ers2647044
17618284Colorectal cancer1.00E-14Illumina [547,647]8q24.21Intergenicrs6983267
17618283Colorectal cancer3.00E-11Illumina and Affymetrix [99,632]8q24.21ORF DQ515897rs10505477
17603472Atrial fibrillation/atrial flutter3.00E-41Illumina [316,515]4q25PITX2,ENPEPrs2200733
17603472Atrial fibrillation/atrial flutter7.00E-11Illumina [316,515]4q25PITX2,ENPEPrs10033464
17603485Prostate cancer1.00E-11Illumina [310,520]17q12TCF2rs4430796
17603485Prostate cancer3.00E-10Illumina [310,520]17q24.3Intergenicrs1859962
17668382Type 2 diabetes5.00E-08Illumina [315,917]10q25.2TCF7L2rs7903146
17668382Type 2 diabetes0.000006Illumina [315,917]2q12.1Intergenicrs6712932
17558408Celiac disease1.00E-14Illumina [310,605]4q27KIAA1109,TENR,IL2,IL21rs6822844
17558408Celiac disease1.00E-19Illumina [310,605]6p21.32HLA-DQA1rs2187668
17553421APOE*e4 carriers with late onset Alzheimer's disease1.00E-10Affymetrix [312,316]11q14.1GAB2rs2373115
17554300Bipolar disorder6.00E-08Affymetrix [469,557]16p12.1PALB2,NDUFAB1,DCTN5rs420259
17554300Bipolar disorder4E-06Affymetrix [469,557]6p21NRrs6458307
17554300Bipolar disorder0.000005Affymetrix [469,557]3q27NRrs683395
17554300Bipolar disorder8E-06Affymetrix [469,557]14q32.33NRrs11622475
17554300Bipolar disorder7E-06Affymetrix [469,557]14q23.1NRrs10134944
17554300Bipolar disorder7E-06Affymetrix [469,557]2q37NRrs2953145
17554300Bipolar disorder7E-06Affymetrix [469,557]20p13NRrs3761218
17554300Coronary disease1.00E-13Affymetrix [469,557]9p21.3CDKN2A,CDKN2Brs1333049
17554300Coronary disease2E-06Affymetrix [469,557]1q43NRrs17672135
17554300Coronary disease4E-06Affymetrix [469,557]22q12NRrs688034
17554300Coronary disease0.000006Affymetrix [469,557]16q23NRrs8055236
17554300Crohn's disease4.00E-08Affymetrix [469,557]3p21.31BSN, MST1rs9858542
17554300Crohn's disease3.00E-07Affymetrix [469,557]5q33.1IRGMrs1000113
17554300Crohn's disease0.000003Affymetrix [469,557]5q31.1Intergenicrs6596075
17554300Crohn's disease2E-06Affymetrix [469,557]10q21.2Intergenicrs10761659
17554300Crohn's disease2.00E-12Affymetrix [469,557]5p13.1Intergenicrs17234657
17554300Crohn's disease5.00E-14Affymetrix [469,557]2q37.1ATG16L1rs10210302
17554300Crohn's disease6.00E-12Affymetrix [469,557]1p31.3IL23Rrs11805303
17554300Crohn's disease4.00E-11Affymetrix [469,557]16q12.1NOD2rs17221417
17554300Crohn's disease0.000009Affymetrix [469,557]10p15.1NRrs6601764
17554300Crohn's disease4E-06Affymetrix [469,557]7q36.1NRrs7807268
17554300Crohn's disease6.00E-08Affymetrix [469,557]10q24.2NKX2-3rs10883365
17554300Crohn's disease2.00E-07Affymetrix [469,557]18p11.21PTPN2rs2542151
17554300Crohn's disease2E-06Affymetrix [469,557]6p21NRrs9469220
17554300Hypertension8.00E-07Affymetrix [469,557]1q43RYR2,CHRM3,ZP4rs2820037
17554300Hypertension0.000006Affymetrix [469,557]15q26NRrs2398162
17554300Rheumatoid arthritis4.00E-07Affymetrix [469,557]7q32.3Intergenicrs11761231
17554300Rheumatoid arthritis1.00E-06Affymetrix [469,557]22q13NRrs743777
17554300Rheumatoid arthritis2E-06Affymetrix [469,557]21q22NRrs2837960
17554300Rheumatoid arthritis5.00E-75Affymetrix [469,557]6p21.32MHCrs6457617
17554300Rheumatoid arthritis6.00E-25Affymetrix [469,557]1p13.2PTPN22rs6679677
17554300Rheumatoid arthritis8.00E-27Affymetrix [469,557]6p21.32HLA-DRB1rs615672
17554300Rheumatoid arthritis0.000009Affymetrix [469,557]4p15.2NRrs3816587
17554300Type 1 diabetes1.00E-11Affymetrix [469,557]12q13.2ERBB3rs11171739
17554300Type 1 diabetes2E-06Affymetrix [469,557]4q27NRrs6534347
17554300Type 1 diabetes0.000005Affymetrix [469,557]5q31.1NRrs17166496
17554300Type 1 diabetes0Affymetrix [469,557]6p21.32MHCrs9272346
17554300Type 1 diabetes5.00E-26Affymetrix [469,557]1p13.2PTPN22rs6679677
17554300Type 1 diabetes5.00E-08Affymetrix [469,557]12p13.31NRrs3764021
17554300Type 1 diabetes2.00E-14Affymetrix [469,557]12q24.13SH2B3,LNK,TRAFD1,PTPN1rs17696736
17554300Type 1 diabetes5.00E-07Affymetrix [469,557]16p13.13KIAA0350rs12708716
17554300Type 1 diabetes7.00E-07Affymetrix [469,557]12p13NRrs11052552
17554300Type 1 diabetes0.000003Affymetrix [469,557]4q27NRrs17388568
17554300Type 2 diabetes3.00E-07Affymetrix [469,557]6p22.3CDKAL1rs9465871
17554300Type 2 diabetes2.00E-07Affymetrix [469,557]16q12.2FTOrs9939609
17554300Type 2 diabetes5.00E-12Affymetrix [469,557]10q25.2TCF7L2rs4506565
17554300Type 2 diabetes0.000009Affymetrix [469,557]4q27NRrs7659604
17554300Type 2 diabetes0.000003Affymetrix [469,557]3p14NRrs358806
17554300Type 2 diabetes7E-06Affymetrix [469,557]12q15NRrs1495377
17554300Type 2 diabetes7E-06Affymetrix [469,557]12q13NRrs12304921
17554261Crohn's disease3.00E-08see WTCCC1q31.2Intergenicrs10801047
17554261Crohn's disease5.00E-08see WTCCC3p21.31MST1rs9858542
17554261Crohn's disease2.00E-10see WTCCC5q33.1IRGMrs13361189
17554261Crohn's disease4.00E-10see WTCCC10q24.2NKX2-3rs10883365
17554261Crohn's disease3.00E-08see WTCCC18p11.21PTPN2rs2542151
17554261Crohn's disease3.00E-18see WTCCC5p13.1Intergenicrs9292777
17554261Crohn's disease0.000009see WTCCC5q33.3IL12Brs6887695
17554261Crohn's disease2.00E-07see WTCCC1q24.3Intergenicrs12035082
17554261Crohn's disease5.00E-07see WTCCC21q22.2Intergenicrs2836754
17554260Type 1 diabetes2.00E-16see WTCCC12q24.13C12orf30rs17696736
17554260Type 1 diabetes2.00E-20see WTCCC12q13.2ERBB3rs2292239
17554260Type 1 diabetes3.00E-18see WTCCC16p13.13KIAA0350rs12708716
17554260Type 1 diabetes1.00E-14see WTCCC18p11.21PTPN2rs2542151
17554260Type 1 diabetes2.00E-11see WTCCC2q24.2IFIH1rs1990760
17554260Type 1 diabetes8E-06see WTCCC5p13.2IL7Rrs6897932
17554260Type 1 diabetes8E-06see WTCCC5p13.2CAPSLrs1445898
17554260Type 1 diabetes2.00E-80see WTCCC1p13.2PTPN22rs2476601
17554260Type 1 diabetes2.00E-07see WTCCC11p15.5INSrs3741208
17554260Type 1 diabetes8.00E-24see WTCCC1p13.2PHTF1, PTPN22rs6679677
17554260Type 1 diabetes0.000005see WTCCC2p11.2AFF3, LOC150577rs9653442
17554260Type 1 diabetes1.00E-08see WTCCC18q22.2CD226rs763361
17529967Breast cancer2.00E-76Perlegen [205,586]10q26.13FGFR2rs2981582
17529967Breast cancer0.000009Perlegen [205,586]5p12Intergenicrs981782
17529967Breast cancer1.00E-36Perlegen [205,586]16q12.1TNCR9,LOC643714rs3803662
17529967Breast cancer7.00E-20Perlegen [205,586]5q11.2MAP3K1rs889312
17529967Breast cancer3.00E-09Perlegen [205,586]11p15.5LSP1rs3817198
17529967Breast cancer5.00E-12Perlegen [205,586]8q24.21Intergenicrs13281615
17529973Breast cancer1.00E-10Illumina [528,173]10q26.13FGFR2rs1219648
17529974Breast cancer1.00E-13Illumina [311,524]2q35Intergenicrs13387042
17529974Breast cancer6.00E-19Illumina [311,524]16q12.1TNRC9rs3803662
17505501Response to ximelagatran treatment0.000009Perlegen [~266,722]6p21.3HLA-DRB1
17486107Bipolar disorder2.00E-08Illumina [555,235] (pooled)13q14.11DGKHrs1012053
17434096Stroke0.000006Illumina [408,803]13q21.1Intergenicrs9536591
17434096Stroke7.00E-07Illumina [408,803]18p11.2IMPA2rs7506045
17434096Stroke0.000006Illumina [408,803]7p21Intergenicrs10486776
17434096Stroke0.000009Illumina [408,803]6q21AIM1rs783396
17478679Myocardial infarction1.00E-20Illumina [305,953]9p21.3CDKN2A,CDKN2Brs10757278
17478681Coronary diseaseNSPerlegen [72,864]NRNR
17470457Episodic memoryNSAffymetrix [~502,627] (pooled)NRNR
17463246Triglycerides3.00E-13Affymetrix [386,731]19q13.32APOE clusterrs4420638
17463246Triglycerides0.000003Affymetrix [386,731]16q13CETPrs1800775
17463246Triglycerides7.00E-07Affymetrix [386,731]2p24.1APOBrs693
17463246Triglycerides3.00E-13Affymetrix [386,731]16q13CETPrs1800775
17463246Triglycerides5.00E-07Affymetrix [386,731]8p21.3LPLrs328
17463246Type 2 diabetes6.00E-10Affymetrix [386,731]10q23.33HHEXrs1111875
17463246Type 2 diabetes8.00E-15Affymetrix [386,731]9p21.3CDKN2A,CDKN2Brs10811661
17463246Type 2 diabetes4.00E-11Affymetrix [386,731]6p22.3CDKAL1rs7754840
17463246Type 2 diabetes9.00E-16Affymetrix [386,731]3q27.2IGF2BP2rs4402960
17463246Type 2 diabetes2E-06Affymetrix [386,731]3p25.2PPARGrs1801282
17463246Type 2 diabetes5.00E-08Affymetrix [386,731]8q24.11SLC30A8rs13266634
17463246Type 2 diabetes1.00E-48Affymetrix [386,731]10q25.2TCF7L2rs7903146
17463246Type 2 diabetes7.00E-11Affymetrix [386,731]11p15.1KCNJ11rs5219
17463248Type 2 diabetes2E-06Illumina [315,635]3p25.2PPARGrs1801282
17463248Type 2 diabetes6.00E-10Illumina [315,635]10q23.33HHEXrs1111875
17463248Type 2 diabetes4.00E-07Illumina [315,635]11p12Intergenicrs9300039
17463248Type 2 diabetes8.00E-15Illumina [315,635]9p21.3CDKN2A, CDKN2Brs10811661
17463248Type 2 diabetes4.00E-11Illumina [315,635]6p22.3CDKAL1rs7754840
17463248Type 2 diabetes9.00E-16Illumina [315,635]3q27.2IGF2BP2rs4402960
17463248Type 2 diabetes7.00E-11Illumina [315,635]11p15.1KCNJ11rs5219
17463248Type 2 diabetes1.00E-48Illumina [315,635]10q25.2TCF7L2rs7903146
17463248Type 2 diabetes5.00E-08Illumina [315,635]8q24.11SLC30A8rs13266634
17460697Type 2 diabetes2.00E-10Illumina [313,179 SNPs; 339,846 2-SNP haplotypes]10q25.2TCF7L2rs7903146
17460697Type 2 diabetes0.000003Illumina [313,179 SNPs; 339,846 2-SNP haplotypes]8q24.11SLC30A8rs13266634
17460697Type 2 diabetes8.00E-09Illumina [313,179 SNPs; 339,846 2-SNP haplotypes]6p22.3CDKAL1rs7756992
17463249Type 2 diabetes1.00E-12Affymetrix [393,453]16q12.2FTOrs8050136
17463249Type 2 diabetes6.00E-10Affymetrix [393,453]10q23.33HHEXrs5015480
17463249Type 2 diabetes9.00E-16Affymetrix [393,453]3q27.2IGF2BP2rs4402960
17463249Type 2 diabetes8.00E-15Affymetrix [393,453]9p21.3CDKN2A/Brs10811661
17463249Type 2 diabetes4.00E-11Affymetrix [393,453]6p22.3CDKAL1rs10946398
17463249Type 2 diabetes1.00E-07Affymetrix [393,453]9p21.3CDKN2Brs564398
17463249Type 2 diabetes2E-06Affymetrix [393,453]3p25.2PPARGrs1801282
17463249Type 2 diabetes5.00E-11Affymetrix [393,453]11p15.1KCNJ11rs5215
17463249Type 2 diabetes1.00E-48Affymetrix [393,453]10q25.2TCF7L2rs7901695
17463249Type 2 diabetes5.00E-08Affymetrix [393,453]8q24.11SLC30A8rs13266634
17435756Crohn's disease1.00E-13Illumina [304,413]2q37.1ATG16L1rs2241880
17435756Crohn's disease7.00E-14Illumina [304,413]16q12.1CARD15rs2076756
17435756Crohn's disease3.00E-12Illumina [304,413]1p31.3IL23Rrs7517847
17435756Crohn's disease1.00E-10Illumina [304,413]10q21.2Intergenicrs224136
17434869Body mass index2.00E-20Affymetrix [490,032]16q12.2FTOrs9939609
17407593Nicotine dependenceNSAffymetrix [~520,000] (pooled)NRNR
17474819Late onset Alzheimer's disease1.00E-39Affymetrix [~502,627]19q13.32APOErs4420638
17401366Prostate cancer3.00E-15Illumina [316,515]8q24.21Intergenicrs10033464
17401366Prostate cancer6.00E-18Illumina [316,515]8q24.21Intergenicrs1447295
17401366Prostate cancer1.00E-12Illumina [316,515]8q24.21Intergenicrs16901979
17395743End-stage renal disease2E-06Affymetrix [115,352]8q24.21PVT1rs2648875
17401363Prostate cancer2.00E-14Illumina [538,548]8q24.21Intergenicrs1447295
17401363Prostate cancer9.00E-13Illumina [538,548]8q24.21Intergenicrs6983267
17522711Schizophrenia4.00E-07Affymetrix [439,511]Xp22.33,Yp11.32CSF2RA,IL3RArs4129148
17357082Progressive supranuclear palsyNSAffymetrix [428,867]NRNR
17447842Crohn's disease2.00E-18Illumina [302,451]1p31.3IL23Rrs11209026
17447842Crohn's disease1.00E-06Illumina [302,451]16q12.1CARD15rs5743289
17447842Crohn's disease2.00E-12Illumina [302,451]5p13.1Intergenicrs1373692
17362836Amyotrophic lateral sclerosis7.00E-07Illumina [549,062]10q26.13Intergenicrs4363506
17362836Amyotrophic lateral sclerosis2E-06Illumina [549,062]2p24Intergenicrs16984239
17362836Amyotrophic lateral sclerosis0.000003Illumina [549,062]8q24.2Intergenicrs12680546
17362836Amyotrophic lateral sclerosis0.000005Illumina [549,062]20q13.2ZFP64rs6013382
17362836Amyotrophic lateral sclerosis0.000006Illumina [549,062]9q31.3SUSD1rs2782931
17362836Amyotrophic lateral sclerosis0.000009Illumina [549,062]4q31.3KlAA1727rs11099864
17293876Type 2 diabetes0.000003Illumina [392,935]10q23.33HHEXrs1111875
17293876Type 2 diabetes2.00E-34Illumina [392,935]10q25.3TCF7L2rs7903146
17293876Type 2 diabetes6.00E-08Illumina [392,935]8q24.11SLC30A8rs13266634
17223258Lung cancerNSAffymetrix [~116,204] (pooled)NRNR
17158188Nicotine dependence2E-06Perlegen [2.4 million] (pooled)21q22.2NRrs2836823
17158188Nicotine dependence0.000006Perlegen [2.4 million] (pooled)10q21.3CTNNA3rs4142041
17099884AddictionNSAffymetrix [639,401]NRNR
17068223Inflammatory bowel disease4.00E-11Illumina [308,332]1p31.3IL23Rrs11209026
17068223Inflammatory bowel disease5.00E-10Illumina [308,332]16q12.1CARD15rs2076756
17068223Inflammatory bowel disease4.00E-13Illumina [308,332]1p31.3IL23Rrs7517847
17053149Memory performanceNSAffymetrix [178,390]NRNR
17053108Wet age-related macular degeneration8.00E-12Affymetrix [97,824]10q26HTRA1rs11200638
17052657Parkinson's disease7E-06Illumina [408,803]11q14DLG2rs10501570
17052657Parkinson's disease2E-06Illumina [408,803]4q13.2BRDG1rs2242330
17052657Parkinson's disease2E-06Illumina [408,803]10q11.21Intergenicrs1480597
16648850QT interval prolongation1.00E-10Affymetrix [88,500]1q23.3NOS1APrs10494366
16614226ObesityNSAffymetrix [86,604]NRNR
16252231Parkinson's disease8E-06Perlegen [198,345]5p15.2SEMA5Ars7702187
15761122Age-related macular degeneration4.00E-08Affymetrix [103,611]1q31CFHrs380390